Gartner (IT) 10-Q2 May 232023 Q1 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares	3 Months Ended
Cover Page - shares	Mar. 31, 2023	Apr. 28, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	1-14443
Entity Registrant Name	Gartner, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	04-3099750
Entity Address, Address Line One	P.O. Box 10212
Entity Address, Address Line Two	56 Top Gallant Road
Entity Address, City or Town	Stamford,
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06902-7700
City Area Code	203
Local Phone Number	964-0096
Title of 12(b) Security	Common Stock, $.0005 par value per share
Trading Symbol	IT
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		79,042,049
Entity Central Index Key	0000749251
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Amendment Flag	false
Current Fiscal Year End Date	--12-31

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 893,512	$ 697,999
Fees receivable, net of allowances of $8,000 and $9,000, respectively	1,523,441	1,556,786
Deferred commissions	343,716	363,079
Prepaid expenses and other current assets	142,650	119,207
Assets held-for-sale	0	49,036
Total current assets	2,903,319	2,786,107
Property, equipment and leasehold improvements, net	256,863	264,581
Operating lease right-of-use assets	415,074	436,592
Goodwill	2,929,941	2,930,211
Intangible assets, net	564,138	584,714
Other assets	309,597	297,531
Total Assets	7,378,932	7,299,736
Current liabilities:
Accounts payable and accrued liabilities	838,784	1,115,198
Deferred revenues	2,607,072	2,443,762
Current portion of long-term debt	8,400	7,800
Liabilities held-for-sale	0	30,840
Total current liabilities	3,454,256	3,597,600
Long-term debt, net of deferred financing fees	2,452,369	2,453,607
Operating lease liabilities	575,963	597,267
Other liabilities	423,486	423,464
Total Liabilities	6,906,074	7,071,938
Stockholders’ Equity
Preferred stock, $0.01 par value, 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.0005 par value, 250,000,000 shares authorized; 163,602,067 shares issued for both periods	82	82
Additional paid-in capital	2,222,511	2,179,604
Accumulated other comprehensive loss, net	(95,910)	(101,610)
Accumulated earnings	4,152,609	3,856,826
Treasury stock, at cost, 84,109,645 and 84,428,513 common shares, respectively	(5,806,434)	(5,707,104)
Total Stockholders’ Equity	472,858	227,798
Total Liabilities and Stockholders’ Equity	$ 7,378,932	$ 7,299,736

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Fees receivable, allowance	$ 8,000	$ 9,000
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0005	$ 0.0005
Common stock, shares authorized (in shares)	250,000,000	250,000,000
Common stock, shares issued (in shares)	163,602,067	163,602,067
Treasury stock, common shares (in shares)	84,109,645	84,428,513

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenues:
Total revenues	$ 1,408,869	$ 1,262,740
Costs and expenses:
Cost of services and product development	435,139	377,033
Selling, general and administrative	657,090	617,904
Depreciation	23,896	23,201
Amortization of intangibles	22,735	25,148
Acquisition and integration charges	1,368	2,207
Gain from sale of divested operation	(139,316)	0
Total costs and expenses	1,000,912	1,045,493
Operating income	407,957	217,247
Interest expense, net	(27,391)	(31,394)
Gain on event cancellation insurance claims	3,077	0
Other (expense) income, net	(2,366)	29,206
Income before income taxes	381,277	215,059
Provision for income taxes	85,494	42,544
Net income	$ 295,783	$ 172,515
Net income per share:
Basic (in dollars per share)	$ 3.72	$ 2.10
Diluted (in dollars per share)	$ 3.68	$ 2.08
Weighted average shares outstanding:
Basic (in shares)	79,452	82,020
Diluted (in shares)	80,282	82,973
Research
Revenues:
Total revenues	$ 1,217,191	$ 1,136,380
Conferences
Revenues:
Total revenues	64,642	10,354
Consulting
Revenues:
Total revenues	$ 127,036	$ 116,006

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 295,783	$ 172,515
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	1,832	(6,798)
Interest rate swaps – net change in deferred gain or loss	3,834	5,370
Pension plans – net change in deferred actuarial loss	34	48
Other comprehensive income (loss), net of tax	5,700	(1,380)
Comprehensive income	$ 301,483	$ 171,135

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss, Net	Accumulated Earnings	Treasury Stock
Beginning balance at Dec. 31, 2021	$ 371,058	$ 82	$ 2,074,896	$ (81,431)	$ 3,049,027	$ (4,671,516)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	172,515				172,515
Other comprehensive income (loss), net	(1,380)			(1,380)
Issuances under stock plans	6,964		579			6,385
Common share repurchases	(463,125)					(463,125)
Stock-based compensation expense	32,121		32,121
Ending balance at Mar. 31, 2022	118,153	82	2,107,596	(82,811)	3,221,542	(5,128,256)
Beginning balance at Dec. 31, 2022	227,798	82	2,179,604	(101,610)	3,856,826	(5,707,104)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	295,783				295,783
Other comprehensive income (loss), net	5,700			5,700
Issuances under stock plans	7,379		(2,141)			9,520
Common share repurchases	(108,850)					(108,850)
Stock-based compensation expense	45,048		45,048
Ending balance at Mar. 31, 2023	$ 472,858	$ 82	$ 2,222,511	$ (95,910)	$ 4,152,609	$ (5,806,434)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating activities:
Net income	$ 295,783	$ 172,515
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	46,631	48,349
Stock-based compensation expense	45,048	32,121
Deferred taxes	(7,866)	(7,502)
Gain from sale of divested operation	(139,316)	0
Loss on impairment of lease related assets	8,720	23,878
Reduction in the carrying amount of operating lease right-of-use assets	17,644	17,951
Amortization and write-off of deferred financing fees	1,161	1,133
Loss (gain) on de-designated swaps	1,393	(29,896)
Changes in assets and liabilities, net of acquisitions and divestitures:
Fees receivable, net	36,177	30,700
Deferred commissions	19,635	18,909
Prepaid expenses and other current assets	(18,370)	(13,596)
Other assets	(14,799)	(1,082)
Deferred revenues	155,153	195,306
Accounts payable and accrued and other liabilities	(282,315)	(321,001)
Cash provided by operating activities	164,679	167,785
Investing activities:
Additions to property, equipment and leasehold improvements	(21,122)	(17,293)
Proceeds from sale of divested operation	158,733	0
Cash provided by (used in) investing activities	137,611	(17,293)
Financing activities:
Proceeds from employee stock purchase plan	7,358	6,949
Payments on borrowings	(1,800)	(1,331)
Purchases of treasury stock	(106,850)	(451,070)
Cash used in financing activities	(101,292)	(445,452)
Net increase (decrease) in cash and cash equivalents and restricted cash	200,998	(294,960)
Effects of exchange rates on cash and cash equivalents	(5,485)	(5,358)
Cash and cash equivalents and restricted cash, beginning of period	698,599	760,602
Cash and cash equivalents and restricted cash, end of period	$ 894,112	$ 460,284

Business and Basis of Presentat

Business and Basis of Presentation	3 Months Ended
Business and Basis of Presentation	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business and Basis of Presentation	Business and Basis of Presentation Business. Gartner, Inc. (NYSE: IT) delivers actionable, objective insight to executives and their teams. Our expert guidance and tools enable faster, smarter decisions and stronger performance on an organization’s mission-critical priorities. Segments . Gartner delivers its products and services globally through three business segments: Research, Conferences and Consulting. Revenues and other financial information for the Company’s segments are discussed in Note 7 — Segment Information. Basis of presentation . The accompanying interim Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”), as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 270 for interim financial information and with the applicable instructions of U.S. Securities and Exchange Commission (“SEC”) Rule 10-01 of Regulation S-X on Form 10-Q, and should be read in conjunction with the consolidated financial statements and related notes of the Company in its Annual Report on Form 10-K for the year ended December 31, 2022. The fiscal year of Gartner is the twelve-month period from January 1 through December 31. In the opinion of management, all normal recurring accruals and adjustments considered necessary for a fair presentation of financial position, results of operations and cash flows at the dates and for the periods presented herein have been included. The results of operations for the three months ended March 31, 2023 may not be indicative of the results of operations for the remainder of 2023 or beyond. When used in these notes, the terms “Gartner,” the “Company,” “we,” “us,” or “our” refer to Gartner, Inc. and its consolidated subsidiaries. Principles of consolidation . The accompanying interim Condensed Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated. Use of estimates . The preparation of the accompanying interim Condensed Consolidated Financial Statements requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. Such estimates include the valuation of fees receivable, goodwill, intangible assets and other long-lived assets, as well as tax accruals and other liabilities. In addition, estimates are used in revenue recognition, income tax expense or benefit, performance-based compensation charges, depreciation and amortization. Management believes its use of estimates in these interim Condensed Consolidated Financial Statements to be reasonable. Management continually evaluates and revises its estimates using historical experience and other factors, including the general economic environment and actions it may take in the future. Management adjusts these estimates when facts and circumstances dictate. However, these estimates may involve significant uncertainties and judgments and cannot be determined with precision. In addition, these estimates are based on management’s best judgment at a point in time. As a result, differences between estimates and actual results could be material and would be reflected in the Company’s consolidated financial statements in future periods. Cash and cash equivalents and restricted cash. Below is a table presenting the beginning-of-period and end-of-period cash amounts from the Company’s Condensed Consolidated Balance Sheets and the total cash amounts presented in the Condensed Consolidated Statements of Cash Flows (in thousands). March 31, December 31, 2023 2022 Cash and cash equivalents $ 893,512 $ 697,999 Restricted cash classified in (1): Other assets 600 600 Cash and cash equivalents and restricted cash $ 894,112 $ 698,599 (1) Restricted cash consisted of an escrow account established in connection with one of the Company’s business acquisitions. Generally, such cash is restricted to use due to provisions contained in the underlying stock or asset purchase agreement. The Company will disburse the restricted cash to the sellers of the business upon satisfaction of any contingencies described in such agreements (e.g., potential indemnification claims, etc.). Revenue recognition. Revenue is recognized in accordance with the requirements of FASB ASC Topic 606, Revenue from Contracts with Customers (“ASC Topic 606”). Revenue is only recognized when all of the required criteria for revenue recognition have been met. The accompanying Condensed Consolidated Statements of Operations present revenue net of any sales or value-added taxes that we collect from customers and remit to government authorities. ASC Topic 270 requires certain disclosures in interim financial statements around the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. Note 4 — Revenue and Related Matters provides additional information regarding the Company’s revenues. Gain on event cancellation insurance claims. In February 2023, the Company received $3.1 million of proceeds related to 2020 event cancellation insurance claims. The Company does not record any gain on insurance claims in excess of expenses incurred until the receipt of the insurance proceeds is deemed to be realizable. Adoption of new accounting standard. The Company adopted the accounting standard described below during the three months ended March 31, 2023. Reference Rate Reform — In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform—Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU No. 2020-04”). ASU No. 2020-04 provides that an entity can elect not to apply certain required modification accounting in U.S. GAAP to contracts where all changes to the critical terms relate to reference rate reform (e.g., the expected discontinuance of LIBOR and the transition to an alternative reference interest rate, etc.). In addition, the rule provides optional expedients and exceptions that enable entities to continue to apply hedge accounting for hedging relationships where one or more of the critical terms change due to reference rate reform. The rule became effective for all entities as of March 12, 2020 and will generally no longer be available to apply after December 31, 2022. ASU No. 2022-06, which was issued in December 2022, extended the deadline to December 31, 2024. During 2023, the Company adopted the practical expedient provided under ASU 2020-04 related to its debt and interest rate swap arrangements and as such, any amendments are treated as a continuation of the existing agreements and no gain or loss on the modification is recorded.

Acquisition and Divestiture

Acquisition and Divestiture	3 Months Ended
Acquisition and Divestiture	Mar. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Acquisitions and Divestiture	Acquisition and Divestiture Acquisition In October 2022, the Company acquired 100% of the outstanding capital stock of UpCity, Inc. (“UpCity”), a privately-held company based in Chicago, Illinois, for an aggregate purchase price of $6.4 million. UpCity’s online marketplace helps small businesses by connecting them to ratings and reviews of more than 50,000 B2B service providers. Divestiture

Goodwill and Intangible Assets

Goodwill and Intangible Assets	3 Months Ended
Goodwill and Intangible Assets	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill Goodwill represents the excess of the purchase price of acquired businesses over the estimated fair values of the tangible and identifiable intangible net assets acquired. Evaluations of the recoverability of goodwill are performed in accordance with FASB ASC Topic 350, which requires an annual assessment of potential goodwill impairment at the reporting unit level and whenever events or changes in circumstances indicate that the carrying value of goodwill may not be recoverable. When performing the annual assessment of the recoverability of goodwill, the Company initially performs a qualitative analysis evaluating whether any events or circumstances occurred or exist that provide evidence that it is more likely than not that the fair value of any of the Company’s reporting units is less than the related carrying amount. If the Company does not believe that it is more likely than not that the fair value of any of the Company’s reporting units is less than the related carrying amount, then no quantitative impairment test is performed. However, if the results of the qualitative assessment indicate that it is more likely than not that the fair value of a reporting unit is less than its respective carrying amount, then a quantitative impairment test is performed. Evaluating the recoverability of goodwill requires judgments and assumptions regarding future trends and events. As a result, both the precision and reliability of the estimates are subject to uncertainty. The Company’s most recent annual impairment test of goodwill was a qualitative analysis conducted during the quarter ended September 30, 2022 that indicated no impairment. Subsequent to completing the 2022 annual impairment test, there were no events or changes in circumstances noted that required an interim impairment test. The table below presents changes to the carrying amount of goodwill by segment during the three months ended March 31, 2023 (in thousands). Research Conferences Consulting Total Balance at December 31, 2022 (1) $ 2,651,193 $ 183,951 $ 95,067 $ 2,930,211 Foreign currency translation impact (390) 1 119 (270) Balance at March 31, 2023 (1) $ 2,650,803 $ 183,952 $ 95,186 $ 2,929,941 (1) The Company does not have any accumulated goodwill impairment losses. Finite-Lived Intangible Assets The tables below present reconciliations of the carrying amounts of the Company’s finite-lived intangible assets as of the dates indicated (in thousands). March 31, 2023 Customer Technology-related Other Total Gross cost at December 31, 2022 $ 1,060,541 $ 11,200 $ 10,436 $ 1,082,177 Foreign currency translation impact 3,931 — — 3,931 Gross cost 1,064,472 11,200 10,436 1,086,108 Accumulated amortization (1) (509,583) (6,533) (5,854) (521,970) Balance at March 31, 2023 $ 554,889 $ 4,667 $ 4,582 $ 564,138 December 31, 2022 Customer Technology-related Other Total Gross cost $ 1,060,541 11,200 $ 10,436 $ 1,082,177 Accumulated amortization (1) (486,260) (5,600) (5,603) (497,463) Balance at December 31, 2022 $ 574,281 $ 5,600 $ 4,833 $ 584,714 (1) Finite-lived intangible assets are amortized using the straight-line method over the following periods: Customer relationships—6 to 13 years; Technology-related—3 years; and Other—4 to 11 years. Amortization expense related to finite-lived intangible assets was $22.7 million and $25.1 million during the three months ended March 31, 2023 and 2022, respectively. The estimated future amortization expense by year for finite-lived intangible assets is presented in the table below (in thousands). 2023 (remaining nine months) $ 68,301 2024 89,160 2025 80,493 2026 77,818 2027 77,210 Thereafter 171,156 $ 564,138

Revenue and Related Matters

Revenue and Related Matters	3 Months Ended
Revenue and Related Matters	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue and Related Matters	Revenue and Related Matters Disaggregated Revenue — The Company’s disaggregated revenue by reportable segment is presented in the tables below for the periods indicated (in thousands). By Primary Geographic Market (1) Three Months Ended March 31, 2023 Primary Geographic Market Research Conferences Consulting Total United States and Canada $ 809,399 $ 48,775 $ 76,975 $ 935,149 Europe, Middle East and Africa 268,657 9,207 32,938 310,802 Other International 139,135 6,660 17,123 162,918 Total revenues $ 1,217,191 $ 64,642 $ 127,036 $ 1,408,869 Three Months Ended March 31, 2022 Primary Geographic Market Research Conferences Consulting Total United States and Canada $ 740,529 $ 7,652 $ 68,789 $ 816,970 Europe, Middle East and Africa 263,129 1,238 32,444 296,811 Other International 132,722 1,464 14,773 148,959 Total revenues $ 1,136,380 $ 10,354 $ 116,006 $ 1,262,740 (1) Revenue is reported based on where the sale is fulfilled. The Company’s revenue is generated primarily through direct sales to clients by domestic and international sales forces and a network of independent international sales agents. Most of the Company’s products and services are provided on an integrated worldwide basis and, because of this integrated delivery approach, it is not practical to precisely separate the Company’s revenue by geographic location. Accordingly, revenue information presented in the above tables is based on internal allocations, which involve certain management estimates and judgments. By Timing of Revenue Recognition Three Months Ended March 31, 2023 Timing of Revenue Recognition Research Conferences Consulting Total Transferred over time (1) $ 1,109,796 $ — $ 97,006 $ 1,206,802 Transferred at a point in time (2) 107,395 64,642 30,030 202,067 Total revenues $ 1,217,191 $ 64,642 $ 127,036 $ 1,408,869 Three Months Ended March 31, 2022 Timing of Revenue Recognition Research Conferences Consulting Total Transferred over time (1) $ 1,025,810 $ — $ 96,436 $ 1,122,246 Transferred at a point in time (2) 110,570 10,354 19,570 140,494 Total revenues $ 1,136,380 $ 10,354 $ 116,006 $ 1,262,740 (1) Research revenues are recognized in connection with performance obligations that are satisfied over time using a time-elapsed output method to measure progress. Consulting revenues are recognized over time using labor hours as an input measurement basis. (2) The revenues in this category are recognized in connection with performance obligations that are satisfied at the point in time that the contractual deliverables are provided to the customer. Performance Obligations — For customer contracts that are greater than one year in duration, the aggregate amount of the transaction price allocated to performance obligations that were unsatisfied (or partially unsatisfied) as of March 31, 2023 was approximately $5.3 billion. The Company expects to recognize $2.4 billion, $2.1 billion and $0.8 billion of this revenue (most of which pertains to Research) during the remainder of 2023, the year ending December 31, 2024 and thereafter, respectively. The Company applies a practical expedient that is permitted under ASC Topic 606 and, accordingly, it does not disclose such performance obligation information for customer contracts that have original durations of one year or less. The Company’s performance obligations for contracts meeting this ASC Topic 606 disclosure exclusion primarily include: (i) stand-ready services under Research subscription contracts; (ii) holding conferences and meetings where attendees and exhibitors can participate; and (iii) providing customized Consulting solutions for clients under fixed fee and time and materials engagements. The remaining duration of these performance obligations is generally less than one year, which aligns with the period that the parties have enforceable rights and obligations under the affected contracts. Customer Contract Assets and Liabilities — The timing of the recognition of revenue and the amount and timing of the Company’s billings and cash collections, including upfront customer payments, result in the recognition of both assets and liabilities on the Company’s Condensed Consolidated Balance Sheets. The table below provides information regarding certain of the Company’s balance sheet accounts that pertain to its contracts with customers (in thousands). March 31, December 31, 2023 2022 Assets: Fees receivable, gross (1) $ 1,531,441 $ 1,565,786 Contract assets recorded in Prepaid expenses and other current assets (2) $ 24,350 $ 21,183 Contract liabilities: Deferred revenues (current liability) (3) $ 2,607,072 $ 2,443,762 Non-current deferred revenues recorded in Other liabilities (3) 32,272 39,115 Total contract liabilities $ 2,639,344 $ 2,482,877 (1) Fees receivable represent an unconditional right to payment from the Company’s customers and include both billed and unbilled amounts. (2) Contract assets represent recognized revenue for which the Company does not have an unconditional right to payment as of the balance sheet date because the project may be subject to a progress billing milestone or some other billing restrictions. (3) Deferred revenues represent amounts (i) for which the Company has received an upfront customer payment or (ii) that pertain to recognized fees receivable. Both situations occur before the completion of the Company’s performance obligation(s).

Computation of Earnings Per Sha

Computation of Earnings Per Share	3 Months Ended
Computation of Earnings Per Share	Mar. 31, 2023
Earnings Per Share [Abstract]
Computation of Earnings Per Share	Computation of Earnings Per Share Basic earnings per share (“EPS”) is computed by dividing net income by the weighted average number of shares of Common Stock outstanding during the period. Diluted EPS reflects the potential dilution of securities that could share in earnings. Potential shares of common stock are excluded from the computation of diluted earnings per share when their effect would be anti-dilutive. The table below sets forth the calculation of basic and diluted income per share for the periods indicated (in thousands, except per share data). Three Months Ended March 31, 2023 2022 Numerator: Net income used for calculating basic and diluted income per share $ 295,783 $ 172,515 Denominator: Weighted average common shares used in the calculation of basic income per share 79,452 82,020 Dilutive effect of outstanding awards associated with stock-based compensation plans (1) 830 953 Shares used in the calculation of diluted income per share 80,282 82,973 Basic income per share $ 3.72 $ 2.10 Diluted income per share $ 3.68 $ 2.08

Stock-Based Compensation

Stock-Based Compensation	3 Months Ended
Stock-Based Compensation	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation The Company grants stock-based compensation awards as an incentive for employees and directors to contribute to the Company’s long-term success. The Company currently awards stock-settled stock appreciation rights, service-based and performance-based restricted stock units, and common stock equivalents. As of March 31, 2023, the Company had 1.9 million shares of its common stock, par value $0.0005 per share, (the “Common Stock”) available for stock-based compensation awards under its current Long-Term Incentive Plan as amended and restated in January 2019 (the “Plan”). The tables below summarize the Company’s stock-based compensation expense by award type and expense category line item during the periods indicated (in millions). Three Months Ended March 31, Award type 2023 2022 Stock appreciation rights $ 2.5 $ 1.9 Restricted stock units 42.2 30.0 Common stock equivalents 0.3 0.2 Total (1) $ 45.0 $ 32.1 Three Months Ended March 31, Expense category line item 2023 2022 Cost of services and product development $ 18.3 $ 11.5 Selling, general and administrative 26.7 20.6 Total (1) $ 45.0 $ 32.1 (1) Includes costs of $26.8 million and $19.2 million during the three months ended March 31, 2023 and 2022, respectively, for awards to retirement-eligible employees. Those awards vest on an accelerated basis.

Segment Information

Segment Information	3 Months Ended
Segment Information	Mar. 31, 2023
Segment Reporting [Abstract]
Segment Information	Segment Information The Company’s products and services are delivered through three segments – Research, Conferences and Consulting, as described below. • Research equips executives and their teams from every function and across all industries with actionable, objective insight, guidance and tools. Our experienced experts deliver all this value informed by an unmatched combination of practitioner-sourced and data-driven research to help our clients address their mission critical priorities. • Conferences provides executives and teams across an organization the opportunity to learn, share and network. From our Gartner Symposium/Xpo series, to industry-leading conferences focused on specific business roles and topics, to peer-driven sessions, our offerings enable attendees to experience the best of Gartner insight and guidance. • Consulting serves senior executives leading technology-driven strategic initiatives leveraging the power of Gartner’s actionable, objective insight. Through custom analysis and on-the-ground support we enable optimized technology investments and stronger performance on our clients’ mission critical priorities. The Company evaluates segment performance and allocates resources based on gross contribution margin. Gross contribution, as presented in the tables below, is defined as operating income or loss excluding certain Cost of services and product development expenses, Selling, general and administrative expenses, Depreciation, Amortization of intangibles, Acquisition and integration charges and Gain from sale of divested operation. Certain bonus and fringe benefit costs included in consolidated Cost of services and product development are not allocated to segment expense. The accounting policies used by the reportable segments are the same as those used by the Company. There are no intersegment revenues. The Company does not identify or allocate assets, including capital expenditures, by reportable segment. Accordingly, assets are not reported by segment because the information is not available by segment and is not reviewed in the evaluation of segment performance or in making decisions regarding the allocation of resources. The tables below present information about the Company’s reportable segments for the periods indicated (in thousands). Three Months Ended March 31, 2023 Research Conferences Consulting Consolidated Revenues $ 1,217,191 $ 64,642 $ 127,036 $ 1,408,869 Gross contribution 899,514 26,788 50,808 977,110 Corporate and other expenses (569,153) Operating income $ 407,957 Three Months Ended March 31, 2022 Research Conferences Consulting Consolidated Revenues $ 1,136,380 $ 10,354 $ 116,006 $ 1,262,740 Gross contribution 849,379 (2,876) 51,012 897,515 Corporate and other expenses (680,268) Operating income $ 217,247 The table below provides a reconciliation of total segment gross contribution to net income for the periods indicated (in thousands). Three Months Ended March 31, 2023 2022 Total segment gross contribution $ 977,110 $ 897,515 Costs and expenses: Cost of services and product development - unallocated (1) 3,380 11,808 Selling, general and administrative 657,090 617,904 Depreciation and amortization 46,631 48,349 Acquisition and integration charges 1,368 2,207 Gain from sale of divested operation (139,316) — Operating income 407,957 217,247 Interest expense and other, net (29,757) (2,188) Gain on event cancellation insurance claims 3,077 — Less: Provision for income taxes 85,494 42,544 Net income $ 295,783 $ 172,515 (1) The unallocated amounts consist of certain bonus and fringe costs recorded in consolidated Cost of services and product development that are not allocated to segment expense. The Company’s policy is to allocate bonuses to segments at 100% of a segment employee’s target bonus. Amounts above or below 100% are absorbed by corporate.

Debt

Debt	3 Months Ended
Debt	Mar. 31, 2023
Debt Disclosure [Abstract]
Debt	Debt The Company’s total outstanding borrowings are summarized in the table below (in thousands). March 31, December 31, Description 2023 2022 2020 Credit Agreement - Term loan facility (1) $ 280,400 $ 282,200 2020 Credit Agreement - Revolving credit facility (1), (2) — — Senior Notes due 2028 (“2028 Notes”) (3) 800,000 800,000 Senior Notes due 2029 (“2029 Notes”) (4) 600,000 600,000 Senior Notes due 2030 (“2030 Notes”) (5) 800,000 800,000 Other (6) 5,000 5,000 Principal amount outstanding (7) 2,485,400 2,487,200 Less: deferred financing fees (8) (24,631) (25,793) Net balance sheet carrying amount $ 2,460,769 $ 2,461,407 (1) The contractual annualized interest rate as of March 31, 2023 on the 2020 Credit Agreement Term loan facility and the Revolving credit facility was 6.13%, which consisted of a floating Eurodollar base rate of 4.875% plus a margin of 1.250%. However, the Company has an interest rate swap contract that effectively convert the floating Eurodollar base rates on outstanding amounts to a fixed base rate. (2) The Company had approximately $1.0 billion of available borrowing capacity on the 2020 Credit Agreement revolver (not including the expansion feature) as of March 31, 2023. (3) Consists of $800.0 million principal amount of 2028 Notes outstanding. The 2028 Notes bear interest at a fixed rate of 4.50% and mature on July 1, 2028. (4) Consists of $600.0 million principal amount of 2029 Notes outstanding. The 2029 Notes bear interest at a fixed rate of 3.625% and mature on June 15, 2029. (5) Consists of $800.0 million principal amount of 2030 Notes outstanding. The 2030 Notes bear interest at a fixed rate of 3.75% and mature on October 1, 2030. (6) Consists of a State of Connecticut economic development loan originated in 2019 with a 10-year maturity and bears interest at a fixed rate of 1.75%. This loan may be repaid at any time by the Company without penalty. (7) The weighted average annual effective rate on the Company’s outstanding debt for the three months ended March 31, 2023, including the effects of its interest rate swaps discussed below, was 5.03%. (8) Deferred financing fees are being amortized to Interest expense, net over the term of the related debt obligation. 2029 Notes On June 18, 2021, the Company issued $600.0 million aggregate principal amount of 3.625% Senior Notes due 2029. The 2029 Notes were issued pursuant to an indenture, dated as of June 18, 2021 (the “2029 Note Indenture”), among the Company, the guarantors party thereto and U.S. Bank National Association, as trustee. The 2029 Notes were issued at an issue price of 100.0% and bear interest at a rate of 3.625% per annum. Interest on the 2029 Notes is payable on June 15 and December 15 of each year, beginning on December 15, 2021. The 2029 Notes will mature on June 15, 2029. The Company may redeem some or all of the 2029 Notes at any time on or after June 15, 2024 for cash at the redemption prices set forth in the 2029 Notes Indenture, plus accrued and unpaid interest to, but excluding, the redemption date. Prior to June 15, 2024, the Company may redeem up to 40% of the aggregate principal amount of the 2029 Notes in connection with certain equity offerings, or some or all of the 2029 Notes with a “make-whole” premium, in each case subject to the terms set forth in the 2029 Note Indenture. 2030 Notes On September 28, 2020, the Company issued $800.0 million aggregate principal amount of 3.75% Senior Notes due 2030. The 2030 Notes were issued pursuant to an indenture, dated as of September 28, 2020 (the “2030 Note Indenture”), among the Company, the guarantors party thereto and U.S. Bank National Association, as trustee. The 2030 Notes were issued at an issue price of 100.0% and bear interest at a rate of 3.75% per annum. Interest on the 2030 Notes is payable on April 1 and October 1 of each year, beginning on April 1, 2021. The 2030 Notes will mature on October 1, 2030. The Company may redeem some or all of the 2030 Notes at any time on or after October 1, 2025 for cash at the redemption prices set forth in the 2030 Note Indenture, plus accrued and unpaid interest to, but excluding, the redemption date. Prior to October 1, 2025, the Company may redeem up to 40% of the aggregate principal amount of the 2030 Notes in connection with certain equity offerings, or some or all of the 2030 Notes with a “make-whole” premium, in each case subject to the terms set forth in the 2030 Note Indenture. 2028 Notes On June 22, 2020, the Company issued $800.0 million aggregate principal amount of 4.50% Senior Notes due 2028. The 2028 Notes were issued pursuant to an indenture, dated as of June 22, 2020 (the “2028 Note Indenture”), among the Company, the guarantors party thereto and U.S. Bank National Association, as trustee. The 2028 Notes were issued at an issue price of 100.0% and bear interest at a rate of 4.50% per annum. Interest on the 2028 Notes is payable on January 1 and July 1 of each year, beginning on January 1, 2021. The 2028 Notes will mature on July 1, 2028. The Company may redeem some or all of the 2028 Notes at any time on or after July 1, 2023 for cash at the redemption prices set forth in the 2028 Note Indenture, plus accrued and unpaid interest to, but excluding, the redemption date. Prior to July 1, 2023, the Company may redeem up to 40% of the aggregate principal amount of the 2028 Notes in connection with certain equity offerings, or some or all of the 2028 Notes with a “make-whole” premium, in each case subject to the terms set forth in the 2028 Note Indenture. 2020 Credit Agreement The Company has a credit facility that currently provides for a $400.0 million Term loan facility and a $1.0 billion Revolving credit facility (the “2020 Credit Agreement”). The 2020 Credit Agreement contains certain customary restrictive loan covenants, including, among others, financial covenants that apply a maximum consolidated leverage ratio and a minimum consolidated interest expense coverage ratio. The Company was in compliance with all financial covenants as of March 31, 2023. The Term loan is being repaid in consecutive quarterly installments that commenced on December 31, 2020, plus a final payment to be made on September 28, 2025. The Revolving credit facility may be borrowed, repaid and re-borrowed through September 28, 2025, at which all then-outstanding amounts must be repaid. Interest Rate Swaps As of March 31, 2023, the Company had one fixed-for-floating interest rate swap contract with a notional value of $350.0 million that matures in 2025. The Company pays a base fixed rate of 3.04% and in return receives a floating Eurodollar base rate on 30-day notional borrowings. Effective June 30, 2020, the Company de-designated all of its interest rate swaps and discontinued hedge accounting. Accordingly, subsequent changes to the fair value of the interest rate swaps are recorded in Other (expense) income, net. The amounts previously recorded in Accumulated other comprehensive loss are amortized into Interest expense, net over the terms of the hedged forecasted interest payments. As of March 31, 2023, $47.2 million is remaining in Accumulated other comprehensive loss, net. See Note 11 — Derivatives and Hedging for the amounts remaining in Accumulated other comprehensive loss, net of tax effect, at March 31, 2023 and December 31, 2022. See Note 12 — Fair Value Disclosures for a discussion of the fair values of Company’s interest rate swaps.

Equity

Equity	3 Months Ended
Equity	Mar. 31, 2023
Stockholders' Equity Note [Abstract]
Equity	Equity Share Repurchase Authorization In 2015, the Company’s Board of Directors (the “Board”) authorized a share repurchase program to repurchase up to $1.2 billion of the Company’s common stock. The Board authorized incremental share repurchases of up to an additional $1.6 billion, $1.0 billion and $0.4 billion of the Company’s common stock during 2021, 2022, and February 2023, respectively. As of March 31, 2023, $954.5 million remained available under the share repurchase program. The Company may repurchase its common stock from time-to-time in amounts, at prices and in the manner that the Company deems appropriate, subject to the availability of stock, prevailing market conditions, the trading price of the stock, the Company’s financial performance and other conditions. Repurchases may be made through open market purchases (which may include repurchase plans designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended), accelerated share repurchases, private transactions or other transactions and will be funded by cash on hand and borrowings. Repurchases may also be made from time-to-time in connection with the settlement of the Company’s stock-based compensation awards. The Company’s share repurchase activity is presented in the table below for the periods indicated. Three Months Ended March 31, 2023 2022 Number of shares repurchased (1) 327,680 1,627,709 Cash paid for repurchased shares (in thousands) (2) $ 106,850 $ 451,070 (1) The average purchase price for repurchased shares was $332.18 and $284.53 for the three months ended March 31, 2023 and 2022, respectively. The repurchased shares during the three months ended March 31, 2023 and 2022 included purchases for both open market purchases and stock-based compensation award settlements. (2) The cash paid for repurchased shares during the three months ended March 31, 2023 excluded $2.0 million of open market purchases with trade dates in March 2023 that settled in April 2023. The cash paid for repurchased shares during the three months ended March 31, 2022 excluded $12.1 million of open market purchases with trade dates in March 2022 that settled in April 2022. Accumulated Other Comprehensive Loss, net (“AOCL”) The tables below provide information about the changes in AOCL by component and the related amounts reclassified out of AOCL to income during the periods indicated (net of tax, in thousands) (1). Three Months Ended March 31, 2023 Interest Rate Defined Foreign Total Balance - Balance at December 31, 2022 $ (39,248) $ (4,247) $ (58,115) $ (101,610) Other comprehensive income (loss) activity during the period: Change in AOCL before reclassifications to income — — 1,832 1,832 Reclassifications from AOCL to income (2), (3) 3,834 34 — 3,868 Other comprehensive income (loss), net 3,834 34 1,832 5,700 Balance – March 31, 2023 $ (35,414) $ (4,213) $ (56,283) $ (95,910) Three Months Ended March 31, 2022 Interest Rate Defined Foreign Total Balance – December 31, 2021 $ (56,323) $ (6,672) $ (18,436) $ (81,431) Other comprehensive income (loss) activity during the period: Change in AOCL before reclassifications to income — — (6,798) (6,798) Reclassifications from AOCL to income (2), (3) 5,370 48 — 5,418 Other comprehensive income (loss), net 5,370 48 (6,798) (1,380) Balance – March 31, 2022 $ (50,953) $ (6,624) $ (25,234) $ (82,811) (1) Amounts in parentheses represent debits (deferred losses). (2) $5.1 million and $7.2 million of the reclassifications related to interest rate swaps (cash flow hedges) were recorded in Interest expense, net, for the three months ended March 31, 2023 and 2022, respectively. See Note 8 — Debt and Note 11 — Derivatives and Hedging for information regarding the cash flow hedges. (3) The reclassifications related to defined benefit pension plans were recorded in Other (expense) income, net.

Income Taxes

Income Taxes	3 Months Ended
Income Taxes	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The provision for income taxes was $85.5 million and $42.5 million for the three months ended March 31, 2023 and 2022, respectively. The effective income tax rate was 22.4% and 19.8% for the three months ended March 31, 2023 and 2022, respectively. The year-over-year increase in the effective income tax rate was primarily due to the sale of the TalentNeuron business. The Company had gross unrecognized tax benefits of $141.0 million on March 31, 2023 and $137.2 million on December 31, 2022. It is reasonably possible that gross unrecognized tax benefits will decrease by approximately $12.3 million within the next twelve months due to the anticipated closure of audits and the expiration of certain statutes of limitation.

Derivatives and Hedging

Derivatives and Hedging	3 Months Ended
Derivatives and Hedging	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives and Hedging	Derivatives and HedgingThe Company enters into a limited number of derivative contracts to mitigate the cash flow risk associated with changes in interest rates on variable-rate debt and changes in foreign exchange rates on forecasted foreign currency transactions. The Company accounts for its outstanding derivative contracts in accordance with FASB ASC Topic 815, which requires all derivatives, including derivatives designated as accounting hedges, to be recorded on the balance sheet at fair value. The tables below provide information regarding the Company’s outstanding derivative contracts as of the dates indicated (in thousands, except for number of contracts). March 31, 2023 Derivative Contract Type Number of Notional Fair Value Balance Unrealized Interest rate swaps (1) 1 $ 350,000 $ 1,681 Other assets $ (35,414) 5,909 Other current assets Foreign currency forwards (2) 38 232,475 (483) Accrued liabilities — Total 39 $ 582,475 $ 7,107 $ (35,414) December 31, 2022 Derivative Contract Type Number of Contracts Notional Fair Value Balance Unrealized Interest rate swaps (1) 1 $ 350,000 $ 3,952 Other assets $ (39,248) 6,346 Other current assets Foreign currency forwards (2) 138 687,763 625 Other current assets — Total 139 $ 1,037,763 $ 10,923 $ (39,248) (1) Effective June 30, 2020, the Company de-designated all of its interest rate swaps and discontinued hedge accounting. Accordingly, subsequent changes to fair value of the interest rate swaps are recorded in Other (expense) income, net. The amounts previously recorded in Accumulated other comprehensive loss are amortized into Interest expense, net over the terms of the hedged forecasted interest payments. See Note 8 — Debt for additional information regarding the Company’s interest rate swap contracts. (2) The Company has foreign exchange transaction risk because it typically enters into transactions in the normal course of business that are denominated in foreign currencies that differ from the local functional currency. The Company enters into short-term foreign currency forward exchange contracts to mitigate the cash flow risk associated with changes in foreign currency rates on forecasted foreign currency transactions. These contracts are accounted for at fair value with realized and unrealized gains and losses recognized in Other (expense) income, net because the Company does not designate these contracts as hedges for accounting purposes. All of the outstanding foreign currency forward exchange contracts at March 31, 2023 matured before April 30, 2023. (3) See Note 12 — Fair Value Disclosures for the determination of the fair values of these instruments. At March 31, 2023, all of the Company’s derivative counterparties were investment grade financial institutions. The Company did not have any collateral arrangements with its derivative counterparties and none of the derivative contracts contained credit-risk related contingent features. The table below provides information regarding amounts recognized in the accompanying Condensed Consolidated Statements of Operations for derivative contracts for the periods indicated (in thousands). Three Months Ended March 31, Amount recorded in: 2023 2022 Interest expense, net (1) $ 5,117 $ 7,166 Other expense (income), net 1,904 (26,900) Total expense (income), net $ 7,021 $ (19,734) (1) Consists of interest expense from interest rate swap contracts.

Fair Value Disclosures

Fair Value Disclosures	3 Months Ended
Fair Value Disclosures	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Disclosures	Fair Value Disclosures The Company’s financial instruments include cash equivalents, fees receivable from customers, accounts payable and accrued liabilities, all of which are normally short-term in nature. The Company believes that the carrying amounts of these financial instruments reasonably approximate their fair values due to their short-term nature. The Company’s financial instruments also include its outstanding variable-rate borrowings under the 2020 Credit Agreement. The Company believes that the carrying amounts of its variable-rate borrowings reasonably approximate their fair values because the rates of interest on those borrowings reflect current market rates of interest for similar instruments with comparable maturities. The Company enters into a limited number of derivatives transactions but does not enter into repurchase agreements, securities lending transactions or master netting arrangements. Receivables or payables that result from derivatives transactions are recorded gross in the Company’s Condensed Consolidated Balance Sheets. FASB ASC Topic 820 provides a framework for the measurement of fair value and a valuation hierarchy based on the transparency of inputs used in the valuation of assets and liabilities. Classification within the valuation hierarchy is based on the lowest level of input that is significant to the resulting fair value measurement. The valuation hierarchy contains three levels. Level 1 measurements consist of quoted prices in active markets for identical assets or liabilities. Level 2 measurements include significant other observable inputs such as quoted prices for similar assets or liabilities in active markets; identical assets or liabilities in inactive markets; observable inputs such as interest rates and yield curves; and other market-corroborated inputs. Level 3 measurements include significant unobservable inputs such as internally-created valuation models. Generally, the Company does not utilize Level 3 valuation inputs to remeasure any of its assets or liabilities. However, Level 3 inputs may be used by the Company when certain long-lived assets, including identifiable intangible assets, goodwill, and right-of-use assets are measured at fair value on a nonrecurring basis when there are indicators of impairment. Additionally, Level 3 inputs may be used by the Company in its required annual impairment review of goodwill. Information regarding the periodic assessment of the Company’s goodwill is included in Note 3 — Goodwill and Intangible Assets. The Company does not typically transfer assets or liabilities between different levels of the valuation hierarchy. The table below presents the fair values of certain financial assets and liabilities that are measured at fair value on a recurring basis in the Company's financial statements (in thousands). Description March 31, December 31, Assets: Values based on Level 1 inputs: Deferred compensation plan assets (1) $ 13,208 $ 6,065 Total Level 1 inputs 13,208 6,065 Values based on Level 2 inputs: Deferred compensation plan assets (1) 89,517 84,318 Foreign currency forward contracts (2) 42 3,236 Interest rate swap contract (3) 7,590 10,298 Total Level 2 inputs 97,149 97,852 Total Assets $ 110,357 $ 103,917 Liabilities: Values based on Level 2 inputs: Deferred compensation plan liabilities (1) $ 108,171 $ 96,641 Foreign currency forward contracts (2) 525 2,611 Total Level 2 inputs 108,696 99,252 Total Liabilities $ 108,696 $ 99,252 (1) The Company has a deferred compensation plan for the benefit of certain highly compensated officers, managers and other key employees. The assets consist of investments in money market funds, mutual funds and company-owned life insurance contracts, which are valued based on Level 1 or Level 2 inputs. The related deferred compensation plan liabilities are recorded at fair value, or the estimated amount needed to settle the liability, which the Company considers to be a Level 2 input. (2) The Company enters into foreign currency forward exchange contracts to hedge the effects of adverse fluctuations in foreign currency exchange rates (see Note 11 — Derivatives and Hedging). Valuation of these contracts is based on observable foreign currency exchange rates in active markets, which the Company considers to be a Level 2 input. (3) The Company has an interest rate swap contract that hedges the risk of variability from interest payments on its borrowings (see Note 8 — Debt). The fair value of the interest rate swap is based on mark-to-market valuations prepared by a third-party broker. This valuation are based on observable interest rates from recently executed market transactions and other observable market data, which the Company considers to be Level 2 inputs. The Company independently corroborates the reasonableness of the valuations prepared by the third-party broker by using an electronic quotation service. The table below presents the carrying amounts (net of deferred financing costs) and fair values of financial instruments that are not recorded at fair value in the Company’s Condensed Consolidated Balance Sheets (in thousands). The estimated fair value of the financial instruments was derived from quoted market prices provided by an independent dealer, which the Company considers to be a Level 2 input. Carrying Amount Fair Value March 31, December 31, March 31, December 31, Description 2023 2022 2023 2022 2028 Notes $ 793,218 $ 792,934 $ 762,480 $ 740,864 2029 Notes 594,158 593,951 539,976 523,842 2030 Notes 792,537 792,324 720,104 688,856 Total $ 2,179,913 $ 2,179,209 $ 2,022,560 $ 1,953,562 Assets and liabilities measured at fair value on a non-recurring basis The Company’s certain long-lived assets, including identifiable intangible assets, goodwill, right-of-use assets and other long-lived assets, are measured at fair value on a nonrecurring basis when there are indicators of impairment. During the three months ended March 31, 2023 and 2022, the Company recorded impairment charges of $8.7 million and $23.9 million, respectively, on right-of-use assets and other long-lived assets primarily related to certain office leases that the Company determined will no longer be used. The impairments were derived by comparing the fair value of the impacted assets to the carrying value of those assets as of the impairment measurement date, as required under ASC Topic 360 using Level 3 inputs. See Note 14 — Leases for additional discussion related to these impairment charges.

Contingencies

Contingencies	3 Months Ended
Contingencies	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies Legal Matters. The Company is involved in legal proceedings and litigation arising in the ordinary course of business. A provision is recorded for pending litigation in the Company’s consolidated financial statements when it is determined that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. The Company believes that the potential liability, if any, in excess of amounts already accrued from all proceedings, claims and litigation will not have a material effect on its financial position, cash flows or results of operations when resolved in a future period. Indemnifications. The Company has various agreements that may obligate it to indemnify the other party with respect to certain matters. Generally, these indemnification clauses are included in contracts arising in the normal course of business under which the Company customarily agrees to hold the other party harmless against losses arising from a breach of representations related to matters such as title to assets sold and licensed or certain intellectual property rights. It is not possible to predict the maximum potential amount of future payments under these indemnification agreements due to the conditional nature of the Company’s obligations and the unique facts of each particular agreement. Historically, payments made by the Company under these agreements have not been material. As of March 31, 2023, the Company did not have any material payment obligations under any such indemnification agreements.

Leases

Leases	3 Months Ended
Leases	Mar. 31, 2023
Leases [Abstract]
Leases	LeasesThe Company’s leasing activities are primarily for facilities under cancelable and non-cancelable lease agreements expiring during 2023 and through 2038. These facilities support our executive and administrative activities, sales, systems support, operations, and other functions. The Company also has leases for office equipment and other assets, which are not significant. Certain of these lease agreements include (i) renewal options to extend the lease term for up to ten years and/or (ii) options to terminate the agreement within one year. Additionally, certain of the Company’s lease agreements provide standard recurring escalations of lease payments for, among other things, increases in a lessor’s maintenance costs and taxes. Under some lease agreements, the Company may be entitled to allowances, free rent, lessor-financed tenant improvements and other incentives. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. The Company subleases certain office space that it does not intend to occupy. Such sublease arrangements expire during 2023 and through 2032 and primarily relate to facilities in Arlington, Virginia. Certain of the Company’s sublease agreements: (i) include renewal and termination options; (ii) provide for customary escalations of lease payments in the normal course of business; and (iii) grant the subtenant certain allowances, free rent, Gartner-financed tenant improvements and other incentives. All of the Company’s leasing and subleasing activity is recognized in Selling, general and administrative expense in the accompanying Condensed Consolidated Statements of Operations. The table below presents the Company’s net lease cost and certain other information related to the Company’s leasing activities as of and for the periods indicated (dollars in thousands). Three Months Ended March 31, Description: 2023 2022 Operating lease cost (1) $ 28,799 $ 30,364 Lease cost (2) 4,720 4,268 Sublease income (12,641) (10,925) Total lease cost, net (3) (4) $ 20,878 $ 23,707 Cash paid for amounts included in the measurement of operating lease liabilities $ 34,948 $ 34,817 Cash receipts from sublease arrangements $ 12,439 $ 11,164 Right-of-use assets obtained in exchange for new operating lease liabilities $ 1,647 $ 6,930 (1) Included in operating lease cost was $10.6 million and $10.5 million for the three months ended March 31, 2023 and 2022, respectively, for costs related to subleasing activities. (2) These amounts are primarily variable lease and nonlease costs that are not fixed at the lease commencement date or are dependent on something other than an index or a rate. (3) The Company did not capitalize any operating lease costs during any of the periods presented. (4) Amount excludes impairment charges on lease related assets totaling $8.7 million and $23.9 million, for the three months ended March 31, 2023 and 2022, respectively, as discussed below. The table below indicates where the discounted operating lease payments from the above table are classified in the accompanying Condensed Consolidated Balance Sheets (in thousands). March 31, December 31, Description: 2023 2022 Accounts payable and accrued liabilities $ 99,674 $ 99,717 Operating lease liabilities 575,963 597,267 Total operating lease liabilities included in the Condensed Consolidated Balance Sheets $ 675,637 $ 696,984 As a result and in consideration of the changing nature of the Company’s use of office space for its workforce and the transitioning to a virtual-first hybrid work environment, the Company has been evaluating its existing real estate lease portfolio. In connection with this evaluation, the Company reviewed certain of its right-of-use assets and related other long-lived assets for impairment under ASC 360. As a result of the evaluation, the Company recognized impairment losses during the three months ended March 31, 2023 and 2022 of $8.7 million and $23.9 million, respectively, which are included as a component of Selling, general and administrative expenses in the accompanying Condensed Consolidated Statements of Operations. The impairment losses recorded include $6.3 million and $17.7 million related to right-of-use assets and $2.4 million and $6.2 million related to other long-lived assets, primarily leasehold improvements, for the three months ended March 31, 2023 and 2022, respectively. The fair values for the asset groups relating to the impaired long-lived assets were estimated primarily using discounted cash flow models (income approach) with Level 3 inputs. The significant assumptions used in estimating fair values include the expected downtime prior to the commencement of future subleases, projected sublease income over the remaining lease periods and discount rates that reflect the level of risk associated with receiving future cash flows.
Leases	LeasesThe Company’s leasing activities are primarily for facilities under cancelable and non-cancelable lease agreements expiring during 2023 and through 2038. These facilities support our executive and administrative activities, sales, systems support, operations, and other functions. The Company also has leases for office equipment and other assets, which are not significant. Certain of these lease agreements include (i) renewal options to extend the lease term for up to ten years and/or (ii) options to terminate the agreement within one year. Additionally, certain of the Company’s lease agreements provide standard recurring escalations of lease payments for, among other things, increases in a lessor’s maintenance costs and taxes. Under some lease agreements, the Company may be entitled to allowances, free rent, lessor-financed tenant improvements and other incentives. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. The Company subleases certain office space that it does not intend to occupy. Such sublease arrangements expire during 2023 and through 2032 and primarily relate to facilities in Arlington, Virginia. Certain of the Company’s sublease agreements: (i) include renewal and termination options; (ii) provide for customary escalations of lease payments in the normal course of business; and (iii) grant the subtenant certain allowances, free rent, Gartner-financed tenant improvements and other incentives. All of the Company’s leasing and subleasing activity is recognized in Selling, general and administrative expense in the accompanying Condensed Consolidated Statements of Operations. The table below presents the Company’s net lease cost and certain other information related to the Company’s leasing activities as of and for the periods indicated (dollars in thousands). Three Months Ended March 31, Description: 2023 2022 Operating lease cost (1) $ 28,799 $ 30,364 Lease cost (2) 4,720 4,268 Sublease income (12,641) (10,925) Total lease cost, net (3) (4) $ 20,878 $ 23,707 Cash paid for amounts included in the measurement of operating lease liabilities $ 34,948 $ 34,817 Cash receipts from sublease arrangements $ 12,439 $ 11,164 Right-of-use assets obtained in exchange for new operating lease liabilities $ 1,647 $ 6,930 (1) Included in operating lease cost was $10.6 million and $10.5 million for the three months ended March 31, 2023 and 2022, respectively, for costs related to subleasing activities. (2) These amounts are primarily variable lease and nonlease costs that are not fixed at the lease commencement date or are dependent on something other than an index or a rate. (3) The Company did not capitalize any operating lease costs during any of the periods presented. (4) Amount excludes impairment charges on lease related assets totaling $8.7 million and $23.9 million, for the three months ended March 31, 2023 and 2022, respectively, as discussed below. The table below indicates where the discounted operating lease payments from the above table are classified in the accompanying Condensed Consolidated Balance Sheets (in thousands). March 31, December 31, Description: 2023 2022 Accounts payable and accrued liabilities $ 99,674 $ 99,717 Operating lease liabilities 575,963 597,267 Total operating lease liabilities included in the Condensed Consolidated Balance Sheets $ 675,637 $ 696,984 As a result and in consideration of the changing nature of the Company’s use of office space for its workforce and the transitioning to a virtual-first hybrid work environment, the Company has been evaluating its existing real estate lease portfolio. In connection with this evaluation, the Company reviewed certain of its right-of-use assets and related other long-lived assets for impairment under ASC 360. As a result of the evaluation, the Company recognized impairment losses during the three months ended March 31, 2023 and 2022 of $8.7 million and $23.9 million, respectively, which are included as a component of Selling, general and administrative expenses in the accompanying Condensed Consolidated Statements of Operations. The impairment losses recorded include $6.3 million and $17.7 million related to right-of-use assets and $2.4 million and $6.2 million related to other long-lived assets, primarily leasehold improvements, for the three months ended March 31, 2023 and 2022, respectively. The fair values for the asset groups relating to the impaired long-lived assets were estimated primarily using discounted cash flow models (income approach) with Level 3 inputs. The significant assumptions used in estimating fair values include the expected downtime prior to the commencement of future subleases, projected sublease income over the remaining lease periods and discount rates that reflect the level of risk associated with receiving future cash flows.

Business and Basis of Present_2

Business and Basis of Presentation (Policies)	3 Months Ended
Business and Basis of Presentation (Policies)	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Segments	Segments . Gartner delivers its products and services globally through three business segments: Research, Conferences and Consulting. Revenues and other financial information for the Company’s segments are discussed in Note 7 — Segment Information.
Basis of presentation	Basis of presentation . The accompanying interim Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”), as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 270 for interim financial information and with the applicable instructions of U.S. Securities and Exchange Commission (“SEC”) Rule 10-01 of Regulation S-X on Form 10-Q, and should be read in conjunction with the consolidated financial statements and related notes of the Company in its Annual Report on Form 10-K for the year ended December 31, 2022.
Principles of consolidation	Principles of consolidation . The accompanying interim Condensed Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated.
Use of estimates	Use of estimates . The preparation of the accompanying interim Condensed Consolidated Financial Statements requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. Such estimates include the valuation of fees receivable, goodwill, intangible assets and other long-lived assets, as well as tax accruals and other liabilities. In addition, estimates are used in revenue recognition, income tax expense or benefit, performance-based compensation charges, depreciation and amortization. Management believes its use of estimates in these interim Condensed Consolidated Financial Statements to be reasonable. Management continually evaluates and revises its estimates using historical experience and other factors, including the general economic environment and actions it may take in the future. Management adjusts these estimates when facts and circumstances dictate. However, these estimates may involve significant uncertainties and judgments and cannot be determined with precision. In addition, these estimates are based on management’s best judgment at a point in time. As a result, differences between estimates and actual results could be material and would be reflected in the Company’s consolidated financial statements in future periods.
Cash and cash equivalents and restricted cash	Cash and cash equivalents and restricted cash. Below is a table presenting the beginning-of-period and end-of-period cash amounts from the Company’s Condensed Consolidated Balance Sheets and the total cash amounts presented in the Condensed Consolidated Statements of Cash Flows (in thousands). March 31, December 31, 2023 2022 Cash and cash equivalents $ 893,512 $ 697,999 Restricted cash classified in (1): Other assets 600 600 Cash and cash equivalents and restricted cash $ 894,112 $ 698,599 (1) Restricted cash consisted of an escrow account established in connection with one of the Company’s business acquisitions. Generally, such cash is restricted to use due to provisions contained in the underlying stock or asset purchase agreement.
Revenue recognition	Revenue recognition. Revenue is recognized in accordance with the requirements of FASB ASC Topic 606, Revenue from Contracts with Customers
Adoption of new accounting standards	Adoption of new accounting standard. The Company adopted the accounting standard described below during the three months ended March 31, 2023. Reference Rate Reform — In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform—Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU No. 2020-04”). ASU No. 2020-04 provides that an entity can elect not to apply certain required modification accounting in U.S. GAAP to contracts where all changes to the critical terms relate to reference rate reform (e.g., the expected discontinuance of LIBOR and the transition to an alternative reference interest rate, etc.). In addition, the rule provides optional expedients and exceptions that enable entities to continue to apply hedge accounting for hedging relationships where one or more of the critical terms change due to reference rate reform. The rule became effective for all entities as of March 12, 2020 and will generally no longer be available to apply after December 31, 2022. ASU No. 2022-06, which was issued in December 2022, extended the deadline to December 31, 2024. During 2023, the Company adopted the practical expedient provided under ASU 2020-04 related to its debt and interest rate swap arrangements and as such, any amendments are treated as a continuation of the existing agreements and no gain or loss on the modification is recorded.

Business and Basis of Present_3

Business and Basis of Presentation (Tables)	3 Months Ended
Business and Basis of Presentation (Tables)	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Cash and Cash Equivalents	Below is a table presenting the beginning-of-period and end-of-period cash amounts from the Company’s Condensed Consolidated Balance Sheets and the total cash amounts presented in the Condensed Consolidated Statements of Cash Flows (in thousands). March 31, December 31, 2023 2022 Cash and cash equivalents $ 893,512 $ 697,999 Restricted cash classified in (1): Other assets 600 600 Cash and cash equivalents and restricted cash $ 894,112 $ 698,599 (1) Restricted cash consisted of an escrow account established in connection with one of the Company’s business acquisitions. Generally, such cash is restricted to use due to provisions contained in the underlying stock or asset purchase agreement.
Restrictions on Cash and Cash Equivalents	Below is a table presenting the beginning-of-period and end-of-period cash amounts from the Company’s Condensed Consolidated Balance Sheets and the total cash amounts presented in the Condensed Consolidated Statements of Cash Flows (in thousands). March 31, December 31, 2023 2022 Cash and cash equivalents $ 893,512 $ 697,999 Restricted cash classified in (1): Other assets 600 600 Cash and cash equivalents and restricted cash $ 894,112 $ 698,599 (1) Restricted cash consisted of an escrow account established in connection with one of the Company’s business acquisitions. Generally, such cash is restricted to use due to provisions contained in the underlying stock or asset purchase agreement.

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	3 Months Ended
Goodwill and Intangible Assets (Tables)	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of changes to the carrying amount of goodwill by reporting unit	The table below presents changes to the carrying amount of goodwill by segment during the three months ended March 31, 2023 (in thousands). Research Conferences Consulting Total Balance at December 31, 2022 (1) $ 2,651,193 $ 183,951 $ 95,067 $ 2,930,211 Foreign currency translation impact (390) 1 119 (270) Balance at March 31, 2023 (1) $ 2,650,803 $ 183,952 $ 95,186 $ 2,929,941 (1) The Company does not have any accumulated goodwill impairment losses.
Schedule of amortizable intangible assets	The tables below present reconciliations of the carrying amounts of the Company’s finite-lived intangible assets as of the dates indicated (in thousands). March 31, 2023 Customer Technology-related Other Total Gross cost at December 31, 2022 $ 1,060,541 $ 11,200 $ 10,436 $ 1,082,177 Foreign currency translation impact 3,931 — — 3,931 Gross cost 1,064,472 11,200 10,436 1,086,108 Accumulated amortization (1) (509,583) (6,533) (5,854) (521,970) Balance at March 31, 2023 $ 554,889 $ 4,667 $ 4,582 $ 564,138 December 31, 2022 Customer Technology-related Other Total Gross cost $ 1,060,541 11,200 $ 10,436 $ 1,082,177 Accumulated amortization (1) (486,260) (5,600) (5,603) (497,463) Balance at December 31, 2022 $ 574,281 $ 5,600 $ 4,833 $ 584,714 (1) Finite-lived intangible assets are amortized using the straight-line method over the following periods: Customer relationships—6 to 13 years; Technology-related—3 years; and Other—4 to 11 years.
Schedule of estimated future amortization expense by year	The estimated future amortization expense by year for finite-lived intangible assets is presented in the table below (in thousands). 2023 (remaining nine months) $ 68,301 2024 89,160 2025 80,493 2026 77,818 2027 77,210 Thereafter 171,156 $ 564,138

Revenue and Related Matters (Ta

Revenue and Related Matters (Tables)	3 Months Ended
Revenue and Related Matters (Tables)	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue by Reportable Segment	Disaggregated Revenue — The Company’s disaggregated revenue by reportable segment is presented in the tables below for the periods indicated (in thousands). By Primary Geographic Market (1) Three Months Ended March 31, 2023 Primary Geographic Market Research Conferences Consulting Total United States and Canada $ 809,399 $ 48,775 $ 76,975 $ 935,149 Europe, Middle East and Africa 268,657 9,207 32,938 310,802 Other International 139,135 6,660 17,123 162,918 Total revenues $ 1,217,191 $ 64,642 $ 127,036 $ 1,408,869 Three Months Ended March 31, 2022 Primary Geographic Market Research Conferences Consulting Total United States and Canada $ 740,529 $ 7,652 $ 68,789 $ 816,970 Europe, Middle East and Africa 263,129 1,238 32,444 296,811 Other International 132,722 1,464 14,773 148,959 Total revenues $ 1,136,380 $ 10,354 $ 116,006 $ 1,262,740 (1) Revenue is reported based on where the sale is fulfilled.
Schedule of Disaggregation of Revenue	By Timing of Revenue Recognition Three Months Ended March 31, 2023 Timing of Revenue Recognition Research Conferences Consulting Total Transferred over time (1) $ 1,109,796 $ — $ 97,006 $ 1,206,802 Transferred at a point in time (2) 107,395 64,642 30,030 202,067 Total revenues $ 1,217,191 $ 64,642 $ 127,036 $ 1,408,869 Three Months Ended March 31, 2022 Timing of Revenue Recognition Research Conferences Consulting Total Transferred over time (1) $ 1,025,810 $ — $ 96,436 $ 1,122,246 Transferred at a point in time (2) 110,570 10,354 19,570 140,494 Total revenues $ 1,136,380 $ 10,354 $ 116,006 $ 1,262,740 (1) Research revenues are recognized in connection with performance obligations that are satisfied over time using a time-elapsed output method to measure progress. Consulting revenues are recognized over time using labor hours as an input measurement basis. (2) The revenues in this category are recognized in connection with performance obligations that are satisfied at the point in time that the contractual deliverables are provided to the customer.
Schedule for Contract with Customer, Asset and Liability	The table below provides information regarding certain of the Company’s balance sheet accounts that pertain to its contracts with customers (in thousands). March 31, December 31, 2023 2022 Assets: Fees receivable, gross (1) $ 1,531,441 $ 1,565,786 Contract assets recorded in Prepaid expenses and other current assets (2) $ 24,350 $ 21,183 Contract liabilities: Deferred revenues (current liability) (3) $ 2,607,072 $ 2,443,762 Non-current deferred revenues recorded in Other liabilities (3) 32,272 39,115 Total contract liabilities $ 2,639,344 $ 2,482,877 (1) Fees receivable represent an unconditional right to payment from the Company’s customers and include both billed and unbilled amounts. (2) Contract assets represent recognized revenue for which the Company does not have an unconditional right to payment as of the balance sheet date because the project may be subject to a progress billing milestone or some other billing restrictions. (3) Deferred revenues represent amounts (i) for which the Company has received an upfront customer payment or (ii) that pertain to recognized fees receivable. Both situations occur before the completion of the Company’s performance obligation(s).

Computation of Earnings Per S_2

Computation of Earnings Per Share (Tables)	3 Months Ended
Computation of Earnings Per Share (Tables)	Mar. 31, 2023
Earnings Per Share [Abstract]
Schedule Of Basic And Diluted Earnings Per Share Calculations	The table below sets forth the calculation of basic and diluted income per share for the periods indicated (in thousands, except per share data). Three Months Ended March 31, 2023 2022 Numerator: Net income used for calculating basic and diluted income per share $ 295,783 $ 172,515 Denominator: Weighted average common shares used in the calculation of basic income per share 79,452 82,020 Dilutive effect of outstanding awards associated with stock-based compensation plans (1) 830 953 Shares used in the calculation of diluted income per share 80,282 82,973 Basic income per share $ 3.72 $ 2.10 Diluted income per share $ 3.68 $ 2.08

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	3 Months Ended
Stock-Based Compensation (Tables)	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of stock-based compensation expense by award type	The tables below summarize the Company’s stock-based compensation expense by award type and expense category line item during the periods indicated (in millions). Three Months Ended March 31, Award type 2023 2022 Stock appreciation rights $ 2.5 $ 1.9 Restricted stock units 42.2 30.0 Common stock equivalents 0.3 0.2 Total (1) $ 45.0 $ 32.1
Schedule of stock-based compensation expense by expense category	Three Months Ended March 31, Expense category line item 2023 2022 Cost of services and product development $ 18.3 $ 11.5 Selling, general and administrative 26.7 20.6 Total (1) $ 45.0 $ 32.1 (1) Includes costs of $26.8 million and $19.2 million during the three months ended March 31, 2023 and 2022, respectively, for awards to retirement-eligible employees. Those awards vest on an accelerated basis.

Segment Information (Tables)

Segment Information (Tables)	3 Months Ended
Segment Information (Tables)	Mar. 31, 2023
Segment Reporting [Abstract]
Schedule of Segment Reporting Information by Segment	The tables below present information about the Company’s reportable segments for the periods indicated (in thousands). Three Months Ended March 31, 2023 Research Conferences Consulting Consolidated Revenues $ 1,217,191 $ 64,642 $ 127,036 $ 1,408,869 Gross contribution 899,514 26,788 50,808 977,110 Corporate and other expenses (569,153) Operating income $ 407,957 Three Months Ended March 31, 2022 Research Conferences Consulting Consolidated Revenues $ 1,136,380 $ 10,354 $ 116,006 $ 1,262,740 Gross contribution 849,379 (2,876) 51,012 897,515 Corporate and other expenses (680,268) Operating income $ 217,247
Schedule of Reconciliation of Segment Gross Contribution to Net Income	The table below provides a reconciliation of total segment gross contribution to net income for the periods indicated (in thousands). Three Months Ended March 31, 2023 2022 Total segment gross contribution $ 977,110 $ 897,515 Costs and expenses: Cost of services and product development - unallocated (1) 3,380 11,808 Selling, general and administrative 657,090 617,904 Depreciation and amortization 46,631 48,349 Acquisition and integration charges 1,368 2,207 Gain from sale of divested operation (139,316) — Operating income 407,957 217,247 Interest expense and other, net (29,757) (2,188) Gain on event cancellation insurance claims 3,077 — Less: Provision for income taxes 85,494 42,544 Net income $ 295,783 $ 172,515 (1) The unallocated amounts consist of certain bonus and fringe costs recorded in consolidated Cost of services and product development that are not allocated to segment expense. The Company’s policy is to allocate bonuses to segments at 100% of a segment employee’s target bonus. Amounts above or below 100% are absorbed by corporate.

Debt (Tables)

Debt (Tables)	3 Months Ended
Debt (Tables)	Mar. 31, 2023
Debt Disclosure [Abstract]
Schedule of Debt	The Company’s total outstanding borrowings are summarized in the table below (in thousands). March 31, December 31, Description 2023 2022 2020 Credit Agreement - Term loan facility (1) $ 280,400 $ 282,200 2020 Credit Agreement - Revolving credit facility (1), (2) — — Senior Notes due 2028 (“2028 Notes”) (3) 800,000 800,000 Senior Notes due 2029 (“2029 Notes”) (4) 600,000 600,000 Senior Notes due 2030 (“2030 Notes”) (5) 800,000 800,000 Other (6) 5,000 5,000 Principal amount outstanding (7) 2,485,400 2,487,200 Less: deferred financing fees (8) (24,631) (25,793) Net balance sheet carrying amount $ 2,460,769 $ 2,461,407 (1) The contractual annualized interest rate as of March 31, 2023 on the 2020 Credit Agreement Term loan facility and the Revolving credit facility was 6.13%, which consisted of a floating Eurodollar base rate of 4.875% plus a margin of 1.250%. However, the Company has an interest rate swap contract that effectively convert the floating Eurodollar base rates on outstanding amounts to a fixed base rate. (2) The Company had approximately $1.0 billion of available borrowing capacity on the 2020 Credit Agreement revolver (not including the expansion feature) as of March 31, 2023. (3) Consists of $800.0 million principal amount of 2028 Notes outstanding. The 2028 Notes bear interest at a fixed rate of 4.50% and mature on July 1, 2028. (4) Consists of $600.0 million principal amount of 2029 Notes outstanding. The 2029 Notes bear interest at a fixed rate of 3.625% and mature on June 15, 2029. (5) Consists of $800.0 million principal amount of 2030 Notes outstanding. The 2030 Notes bear interest at a fixed rate of 3.75% and mature on October 1, 2030. (6) Consists of a State of Connecticut economic development loan originated in 2019 with a 10-year maturity and bears interest at a fixed rate of 1.75%. This loan may be repaid at any time by the Company without penalty. (7) The weighted average annual effective rate on the Company’s outstanding debt for the three months ended March 31, 2023, including the effects of its interest rate swaps discussed below, was 5.03%. (8) Deferred financing fees are being amortized to Interest expense, net over the term of the related debt obligation.

Equity (Tables)

Equity (Tables)	3 Months Ended
Equity (Tables)	Mar. 31, 2023
Stockholders' Equity Note [Abstract]
Schedule of share repurchase activity	The Company’s share repurchase activity is presented in the table below for the periods indicated. Three Months Ended March 31, 2023 2022 Number of shares repurchased (1) 327,680 1,627,709 Cash paid for repurchased shares (in thousands) (2) $ 106,850 $ 451,070 (1) The average purchase price for repurchased shares was $332.18 and $284.53 for the three months ended March 31, 2023 and 2022, respectively. The repurchased shares during the three months ended March 31, 2023 and 2022 included purchases for both open market purchases and stock-based compensation award settlements.
Schedule of the changes in Accumulated Other Comprehensive Loss by component (net of tax)	The tables below provide information about the changes in AOCL by component and the related amounts reclassified out of AOCL to income during the periods indicated (net of tax, in thousands) (1). Three Months Ended March 31, 2023 Interest Rate Defined Foreign Total Balance - Balance at December 31, 2022 $ (39,248) $ (4,247) $ (58,115) $ (101,610) Other comprehensive income (loss) activity during the period: Change in AOCL before reclassifications to income — — 1,832 1,832 Reclassifications from AOCL to income (2), (3) 3,834 34 — 3,868 Other comprehensive income (loss), net 3,834 34 1,832 5,700 Balance – March 31, 2023 $ (35,414) $ (4,213) $ (56,283) $ (95,910) Three Months Ended March 31, 2022 Interest Rate Defined Foreign Total Balance – December 31, 2021 $ (56,323) $ (6,672) $ (18,436) $ (81,431) Other comprehensive income (loss) activity during the period: Change in AOCL before reclassifications to income — — (6,798) (6,798) Reclassifications from AOCL to income (2), (3) 5,370 48 — 5,418 Other comprehensive income (loss), net 5,370 48 (6,798) (1,380) Balance – March 31, 2022 $ (50,953) $ (6,624) $ (25,234) $ (82,811) (1) Amounts in parentheses represent debits (deferred losses). (2) $5.1 million and $7.2 million of the reclassifications related to interest rate swaps (cash flow hedges) were recorded in Interest expense, net, for the three months ended March 31, 2023 and 2022, respectively. See Note 8 — Debt and Note 11 — Derivatives and Hedging for information regarding the cash flow hedges.

Derivatives and Hedging (Tables

Derivatives and Hedging (Tables)	3 Months Ended
Derivatives and Hedging (Tables)	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Notional Amounts of Outstanding Derivative Positions	The tables below provide information regarding the Company’s outstanding derivative contracts as of the dates indicated (in thousands, except for number of contracts). March 31, 2023 Derivative Contract Type Number of Notional Fair Value Balance Unrealized Interest rate swaps (1) 1 $ 350,000 $ 1,681 Other assets $ (35,414) 5,909 Other current assets Foreign currency forwards (2) 38 232,475 (483) Accrued liabilities — Total 39 $ 582,475 $ 7,107 $ (35,414) December 31, 2022 Derivative Contract Type Number of Contracts Notional Fair Value Balance Unrealized Interest rate swaps (1) 1 $ 350,000 $ 3,952 Other assets $ (39,248) 6,346 Other current assets Foreign currency forwards (2) 138 687,763 625 Other current assets — Total 139 $ 1,037,763 $ 10,923 $ (39,248) (1) Effective June 30, 2020, the Company de-designated all of its interest rate swaps and discontinued hedge accounting. Accordingly, subsequent changes to fair value of the interest rate swaps are recorded in Other (expense) income, net. The amounts previously recorded in Accumulated other comprehensive loss are amortized into Interest expense, net over the terms of the hedged forecasted interest payments. See Note 8 — Debt for additional information regarding the Company’s interest rate swap contracts. (2) The Company has foreign exchange transaction risk because it typically enters into transactions in the normal course of business that are denominated in foreign currencies that differ from the local functional currency. The Company enters into short-term foreign currency forward exchange contracts to mitigate the cash flow risk associated with changes in foreign currency rates on forecasted foreign currency transactions. These contracts are accounted for at fair value with realized and unrealized gains and losses recognized in Other (expense) income, net because the Company does not designate these contracts as hedges for accounting purposes. All of the outstanding foreign currency forward exchange contracts at March 31, 2023 matured before April 30, 2023. (3) See Note 12 — Fair Value Disclosures for the determination of the fair values of these instruments.
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance	The table below provides information regarding amounts recognized in the accompanying Condensed Consolidated Statements of Operations for derivative contracts for the periods indicated (in thousands). Three Months Ended March 31, Amount recorded in: 2023 2022 Interest expense, net (1) $ 5,117 $ 7,166 Other expense (income), net 1,904 (26,900) Total expense (income), net $ 7,021 $ (19,734) (1) Consists of interest expense from interest rate swap contracts.

Fair Value Disclosures (Tables)

Fair Value Disclosures (Tables)	3 Months Ended
Fair Value Disclosures (Tables)	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured to Fair Value on Recurring Basis	The table below presents the fair values of certain financial assets and liabilities that are measured at fair value on a recurring basis in the Company's financial statements (in thousands). Description March 31, December 31, Assets: Values based on Level 1 inputs: Deferred compensation plan assets (1) $ 13,208 $ 6,065 Total Level 1 inputs 13,208 6,065 Values based on Level 2 inputs: Deferred compensation plan assets (1) 89,517 84,318 Foreign currency forward contracts (2) 42 3,236 Interest rate swap contract (3) 7,590 10,298 Total Level 2 inputs 97,149 97,852 Total Assets $ 110,357 $ 103,917 Liabilities: Values based on Level 2 inputs: Deferred compensation plan liabilities (1) $ 108,171 $ 96,641 Foreign currency forward contracts (2) 525 2,611 Total Level 2 inputs 108,696 99,252 Total Liabilities $ 108,696 $ 99,252 (1) The Company has a deferred compensation plan for the benefit of certain highly compensated officers, managers and other key employees. The assets consist of investments in money market funds, mutual funds and company-owned life insurance contracts, which are valued based on Level 1 or Level 2 inputs. The related deferred compensation plan liabilities are recorded at fair value, or the estimated amount needed to settle the liability, which the Company considers to be a Level 2 input. (2) The Company enters into foreign currency forward exchange contracts to hedge the effects of adverse fluctuations in foreign currency exchange rates (see Note 11 — Derivatives and Hedging). Valuation of these contracts is based on observable foreign currency exchange rates in active markets, which the Company considers to be a Level 2 input. (3) The Company has an interest rate swap contract that hedges the risk of variability from interest payments on its borrowings (see Note 8 — Debt). The fair value of the interest rate swap is based on mark-to-market valuations prepared by a third-party broker. This valuation are based on observable interest rates from recently executed market transactions and other observable market data, which the Company considers to be Level 2 inputs. The Company independently corroborates the reasonableness of the valuations prepared by the third-party broker by using an electronic quotation service.
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments	The table below presents the carrying amounts (net of deferred financing costs) and fair values of financial instruments that are not recorded at fair value in the Company’s Condensed Consolidated Balance Sheets (in thousands). The estimated fair value of the financial instruments was derived from quoted market prices provided by an independent dealer, which the Company considers to be a Level 2 input. Carrying Amount Fair Value March 31, December 31, March 31, December 31, Description 2023 2022 2023 2022 2028 Notes $ 793,218 $ 792,934 $ 762,480 $ 740,864 2029 Notes 594,158 593,951 539,976 523,842 2030 Notes 792,537 792,324 720,104 688,856 Total $ 2,179,913 $ 2,179,209 $ 2,022,560 $ 1,953,562

Leases (Tables)

Leases (Tables)	3 Months Ended
Leases (Tables)	Mar. 31, 2023
Leases [Abstract]
Lease costs	The table below presents the Company’s net lease cost and certain other information related to the Company’s leasing activities as of and for the periods indicated (dollars in thousands). Three Months Ended March 31, Description: 2023 2022 Operating lease cost (1) $ 28,799 $ 30,364 Lease cost (2) 4,720 4,268 Sublease income (12,641) (10,925) Total lease cost, net (3) (4) $ 20,878 $ 23,707 Cash paid for amounts included in the measurement of operating lease liabilities $ 34,948 $ 34,817 Cash receipts from sublease arrangements $ 12,439 $ 11,164 Right-of-use assets obtained in exchange for new operating lease liabilities $ 1,647 $ 6,930 (1) Included in operating lease cost was $10.6 million and $10.5 million for the three months ended March 31, 2023 and 2022, respectively, for costs related to subleasing activities. (2) These amounts are primarily variable lease and nonlease costs that are not fixed at the lease commencement date or are dependent on something other than an index or a rate. (3) The Company did not capitalize any operating lease costs during any of the periods presented. (4) Amount excludes impairment charges on lease related assets totaling $8.7 million and $23.9 million, for the three months ended March 31, 2023 and 2022, respectively, as discussed below.
Supplemental balance sheet information	The table below indicates where the discounted operating lease payments from the above table are classified in the accompanying Condensed Consolidated Balance Sheets (in thousands). March 31, December 31, Description: 2023 2022 Accounts payable and accrued liabilities $ 99,674 $ 99,717 Operating lease liabilities 575,963 597,267 Total operating lease liabilities included in the Condensed Consolidated Balance Sheets $ 675,637 $ 696,984

Business and Basis of Present_4

Business and Basis of Presentation - Narrative (Details) $ in Millions	1 Months Ended	3 Months Ended
	Feb. 28, 2023 USD ($)	Mar. 31, 2023 segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of reportable segments \| segment		3
Proceeds from event cancellation insurance claims \| $	$ 3.1

Business and Basis of Present_5

Business and Basis of Presentation - Cash and Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash and cash equivalents	$ 893,512	$ 697,999
Other assets	600	600
Cash and cash equivalents and restricted cash	$ 894,112	$ 698,599	$ 460,284	$ 760,602

Acquisition and Divestiture (De

Acquisition and Divestiture (Details) - USD ($) $ in Thousands	1 Months Ended		3 Months Ended
	Feb. 28, 2023	Oct. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Business Acquisition [Line Items]
Proceeds from sale of divested operation			$ 158,733	$ 0
Gain from sale of divested operation			139,316	$ 0
TalentNeuron
Business Acquisition [Line Items]
Sale of business, consideration	$ 164,200
Proceeds from sale of divested operation	$ 158,700
Gain from sale of divested operation			139,300
Goodwill			16,000
Intangible assets, net			9,500
Property, equipment and leasehold improvements, net,			4,500
Accounts receivable			11,800
Deferred revenues			$ 24,400
Chicago, Illinois
Business Acquisition [Line Items]
Percent of outstanding membership interests acquired		100%
Purchase price		$ 6,400

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Changes to the Carrying Amount of Goodwill by Segment (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Sep. 30, 2022
Goodwill [Line Items]
Goodwill impairment		$ 0
Goodwill [Roll Forward]
Beginning balance	$ 2,930,211,000
Foreign currency translation impact	(270,000)
Ending balance	2,929,941,000
Goodwill, accumulated impairment losses	0
Research
Goodwill [Roll Forward]
Beginning balance	2,651,193,000
Foreign currency translation impact	(390,000)
Ending balance	2,650,803,000
Conferences
Goodwill [Roll Forward]
Beginning balance	183,951,000
Foreign currency translation impact	1,000
Ending balance	183,952,000
Consulting
Goodwill [Roll Forward]
Beginning balance	95,067,000
Foreign currency translation impact	119,000
Ending balance	$ 95,186,000

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Carrying Amounts of Amortizable Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Finite-lived Intangible Assets [Roll Forward]
Gross cost, beginning balance	$ 1,082,177
Foreign currency translation impact	3,931
Gross cost, ending balance	1,086,108
Accumulated amortization	(521,970)		$ (497,463)
Finite-lived intangible assets, net	564,138		584,714
Amortization of intangibles	22,735	$ 25,148
Customer Relationships
Finite-lived Intangible Assets [Roll Forward]
Gross cost, beginning balance	1,060,541
Foreign currency translation impact	3,931
Gross cost, ending balance	1,064,472
Accumulated amortization	(509,583)		(486,260)
Finite-lived intangible assets, net	$ 554,889		574,281
Customer Relationships \| Minimum
Finite-lived Intangible Assets [Roll Forward]
Remaining amortization period	6 years
Customer Relationships \| Maximum
Finite-lived Intangible Assets [Roll Forward]
Remaining amortization period	13 years
Technology-related
Finite-lived Intangible Assets [Roll Forward]
Gross cost, beginning balance	$ 11,200
Foreign currency translation impact	0
Gross cost, ending balance	11,200
Accumulated amortization	(6,533)		(5,600)
Finite-lived intangible assets, net	$ 4,667		5,600
Remaining amortization period	3 years
Other
Finite-lived Intangible Assets [Roll Forward]
Gross cost, beginning balance	$ 10,436
Foreign currency translation impact	0
Gross cost, ending balance	10,436
Accumulated amortization	(5,854)		(5,603)
Finite-lived intangible assets, net	$ 4,582		$ 4,833
Other \| Minimum
Finite-lived Intangible Assets [Roll Forward]
Remaining amortization period	4 years
Other \| Maximum
Finite-lived Intangible Assets [Roll Forward]
Remaining amortization period	11 years

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Estimated Future Amortization Expense By Year From Amortizable Intangibles (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2023 (remaining nine months)	$ 68,301
2024	89,160
2025	80,493
2026	77,818
2027	77,210
Thereafter	171,156
Finite-lived intangible assets, net	$ 564,138	$ 584,714

Revenue and Related Matters - D

Revenue and Related Matters - Disaggregation of Revenue by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Disaggregation of Revenue [Line Items]
Total revenues	$ 1,408,869	$ 1,262,740
United States and Canada
Disaggregation of Revenue [Line Items]
Total revenues	935,149	816,970
Europe, Middle East and Africa
Disaggregation of Revenue [Line Items]
Total revenues	310,802	296,811
Other International
Disaggregation of Revenue [Line Items]
Total revenues	162,918	148,959
Research
Disaggregation of Revenue [Line Items]
Total revenues	1,217,191	1,136,380
Research \| United States and Canada
Disaggregation of Revenue [Line Items]
Total revenues	809,399	740,529
Research \| Europe, Middle East and Africa
Disaggregation of Revenue [Line Items]
Total revenues	268,657	263,129
Research \| Other International
Disaggregation of Revenue [Line Items]
Total revenues	139,135	132,722
Conferences
Disaggregation of Revenue [Line Items]
Total revenues	64,642	10,354
Conferences \| United States and Canada
Disaggregation of Revenue [Line Items]
Total revenues	48,775	7,652
Conferences \| Europe, Middle East and Africa
Disaggregation of Revenue [Line Items]
Total revenues	9,207	1,238
Conferences \| Other International
Disaggregation of Revenue [Line Items]
Total revenues	6,660	1,464
Consulting
Disaggregation of Revenue [Line Items]
Total revenues	127,036	116,006
Consulting \| United States and Canada
Disaggregation of Revenue [Line Items]
Total revenues	76,975	68,789
Consulting \| Europe, Middle East and Africa
Disaggregation of Revenue [Line Items]
Total revenues	32,938	32,444
Consulting \| Other International
Disaggregation of Revenue [Line Items]
Total revenues	$ 17,123	$ 14,773

Revenue and Related Matters - T

Revenue and Related Matters - Timing Of Revenue Recognition Liabilities per Segment (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Disaggregation of Revenue [Line Items]
Total revenues	$ 1,408,869	$ 1,262,740
Transferred over time
Disaggregation of Revenue [Line Items]
Total revenues	1,206,802	1,122,246
Transferred at a point in time
Disaggregation of Revenue [Line Items]
Total revenues	202,067	140,494
Research
Disaggregation of Revenue [Line Items]
Total revenues	1,217,191	1,136,380
Research \| Transferred over time
Disaggregation of Revenue [Line Items]
Total revenues	1,109,796	1,025,810
Research \| Transferred at a point in time
Disaggregation of Revenue [Line Items]
Total revenues	107,395	110,570
Conferences
Disaggregation of Revenue [Line Items]
Total revenues	64,642	10,354
Conferences \| Transferred over time
Disaggregation of Revenue [Line Items]
Total revenues	0	0
Conferences \| Transferred at a point in time
Disaggregation of Revenue [Line Items]
Total revenues	64,642	10,354
Consulting
Disaggregation of Revenue [Line Items]
Total revenues	127,036	116,006
Consulting \| Transferred over time
Disaggregation of Revenue [Line Items]
Total revenues	97,006	96,436
Consulting \| Transferred at a point in time
Disaggregation of Revenue [Line Items]
Total revenues	$ 30,030	$ 19,570

Revenue and Related Matters - R

Revenue and Related Matters - Revenue Remaining Performance Obligation (Details) $ in Billions	Mar. 31, 2023 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, amount	$ 5.3
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, amount	$ 2.4
Revenue, remaining performance obligation, expected timing of satisfaction, period	9 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, amount	$ 2.1
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, amount	$ 0.8
Revenue, remaining performance obligation, expected timing of satisfaction, period

Revenue and Related Matters - S

Revenue and Related Matters - Schedule of Contract with Customer, Asset and Liability (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Assets:
Fees receivable, gross	$ 1,531,441		$ 1,565,786
Contract assets recorded in Prepaid expenses and other current assets	24,350		21,183
Contract liabilities:
Deferred revenues (current liability)	2,607,072		2,443,762
Non-current deferred revenues recorded in Other liabilities	32,272		39,115
Total contract liabilities	2,639,344		$ 2,482,877
Revenue recognized previously attributable to deferred revenues	$ 924,900	$ 833,900

Computation of Earnings Per S_3

Computation of Earnings Per Share - Calculations Of Basic And Diluted (Loss) Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Numerator:
Net income used for calculating basic and diluted income per share	$ 295,783	$ 172,515
Denominator:
Weighted average number of common shares used in the calculation of basic income per share (in shares)	79,452	82,020
Dilutive effect of outstanding awards associated with stock-based compensation plans (in shares)	830	953
Shares used in the calculation of diluted income per share (in shares)	80,282	82,973
Basic income per share (in dollars per share)	$ 3.72	$ 2.10
Diluted income per share (in dollars per share)	$ 3.68	$ 2.08

Computation of Earnings Per S_4

Computation of Earnings Per Share - Additional information (Details) - shares shares in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Earnings Per Share [Abstract]
Antidilutive securities excluded from computation of (loss) income per share (in shares)	0.3	0.2

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) - $ / shares shares in Millions	Mar. 31, 2023	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Number of shares available for grant (in shares)	1.9
Common stock par value (in dollars per share)	$ 0.0005	$ 0.0005

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock-based Compensation Expense by Award Type and Expense Category (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 45	$ 32.1
Cost of services and product development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	18.3	11.5
Selling, general and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	26.7	20.6
Stock appreciation rights
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	2.5	1.9
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	42.2	30
Common stock equivalents
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	0.3	0.2
Retirement Eligible Employees Equity Award
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 26.8	$ 19.2

Segment Information - Informati

Segment Information - Information About Reportable Segments (Details)	3 Months Ended
	Mar. 31, 2023 USD ($) segment	Mar. 31, 2022 USD ($)
Segment Reporting Information [Line Items]
Number of reportable segments \| segment	3
Operating income	$ 407,957,000	$ 217,247,000
Intersegment Eliminations
Segment Reporting Information [Line Items]
Revenues	0
Operating Segments
Segment Reporting Information [Line Items]
Revenues	1,408,869,000	1,262,740,000
Operating income	977,110,000	897,515,000
Operating Segments \| Research
Segment Reporting Information [Line Items]
Revenues	1,217,191,000	1,136,380,000
Operating income	899,514,000	849,379,000
Operating Segments \| Conferences
Segment Reporting Information [Line Items]
Revenues	64,642,000	10,354,000
Operating income	26,788,000	(2,876,000)
Operating Segments \| Consulting
Segment Reporting Information [Line Items]
Revenues	127,036,000	116,006,000
Operating income	50,808,000	51,012,000
Corporate and Reconciling Items
Segment Reporting Information [Line Items]
Operating income	$ (569,153,000)	$ (680,268,000)

Segment Information - Reconcili

Segment Information - Reconciliation of Segment Gross Contribution to Net Income (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total segment gross contribution	$ 407,957	$ 217,247
Costs and expenses:
Cost of services and product development - unallocated	435,139	377,033
Selling, general and administrative	657,090	617,904
Acquisition and integration charges	1,368	2,207
Gain from sale of divested operation	(139,316)	0
Operating income	407,957	217,247
Interest expense and other, net	(29,757)	(2,188)
Gain on event cancellation insurance claims	3,077	0
Less: Provision for income taxes	85,494	42,544
Net income	$ 295,783	172,515
Maximum
Costs and expenses:
Percent of target bonus charges allocated to segments	100%
Operating Segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total segment gross contribution	$ 977,110	897,515
Costs and expenses:
Operating income	977,110	897,515
Corporate and Reconciling Items
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total segment gross contribution	(569,153)	(680,268)
Costs and expenses:
Cost of services and product development - unallocated	3,380	11,808
Selling, general and administrative	657,090	617,904
Depreciation and amortization	46,631	48,349
Acquisition and integration charges	1,368	2,207
Operating income	$ (569,153)	$ (680,268)

Debt - Borrowings (Details)

Debt - Borrowings (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Principal amount outstanding	$ 2,485,400	$ 2,487,200
Less: deferred financing fees	(24,631)	(25,793)
Net balance sheet carrying amount	2,460,769	2,461,407
Term Loan Facility \| 2020 Credit Agreement
Debt Instrument [Line Items]
Principal amount outstanding	280,400	282,200
Line of Credit \| Revolving credit facility \| 2020 Credit Agreement
Debt Instrument [Line Items]
Principal amount outstanding	0	0
Senior Notes \| 2028 Notes
Debt Instrument [Line Items]
Principal amount outstanding	800,000	800,000
Senior Notes \| 2029 Notes
Debt Instrument [Line Items]
Principal amount outstanding	600,000	600,000
Senior Notes \| 2030 Notes
Debt Instrument [Line Items]
Principal amount outstanding	800,000	800,000
Other
Debt Instrument [Line Items]
Principal amount outstanding	$ 5,000	$ 5,000

Debt - Footnote to Borrowings (

Debt - Footnote to Borrowings (Details) - USD ($)	3 Months Ended
Debt - Footnote to Borrowings (Details) - USD ($)	Mar. 31, 2023	Jun. 18, 2021	Sep. 28, 2020	Jun. 22, 2020
Debt Instrument [Line Items]
Weighted average annual effective rate	5.03%
Term Loan Facility \| 2020 Credit Agreement
Debt Instrument [Line Items]
Contractual annualized interest rate	6.13%
Floating eurodollar base rate	4.875%
Additional interest above base rate	1.25%
Aggregate principal amount			$ 400,000,000
Line of Credit \| Revolving credit facility \| 2020 Credit Agreement
Debt Instrument [Line Items]
Remaining borrowing capacity	$ 1,000,000,000
Senior Notes \| 2028 Notes
Debt Instrument [Line Items]
Aggregate principal amount	800,000,000			$ 800,000,000
Debt instrument, fixed interest rate				4.50%
Senior Notes \| 2029 Notes
Debt Instrument [Line Items]
Aggregate principal amount	600,000,000	$ 600,000,000
Debt instrument, fixed interest rate		3.625%
Senior Notes \| 2030 Notes
Debt Instrument [Line Items]
Aggregate principal amount	$ 800,000,000		$ 800,000,000
Debt instrument, fixed interest rate			3.75%
Connecticut Economic Development Program \| Economic Development Loan 2
Debt Instrument [Line Items]
Debt instrument, fixed interest rate	1.75%
Debt term	10 years

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($)	Jun. 18, 2021	Sep. 28, 2020	Jun. 22, 2020	Mar. 31, 2023
2029 Notes \| Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount	$ 600,000,000			$ 600,000,000
Debt instrument, fixed interest rate	3.625%
Debt instrument, issue price, percent	100%
2029 Notes \| Senior Notes \| Debt Instrument Redemption Option One
Debt Instrument [Line Items]
Percentage of principal amount redeemed	40%
2030 Notes \| Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount		$ 800,000,000		800,000,000
Debt instrument, fixed interest rate		3.75%
Debt instrument, issue price, percent		100%
Percentage of principal amount redeemed		40%
2028 Notes \| Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount			$ 800,000,000	$ 800,000,000
Debt instrument, fixed interest rate			4.50%
Debt instrument, issue price, percent			100%
Percentage of principal amount redeemed			40%
2020 Credit Agreement \| Variable Rate Component, One \| Federal Reserve Board of New York Rate
Debt Instrument [Line Items]
Basis spread on variable rate		0.50%
2020 Credit Agreement \| Term Loan Facility
Debt Instrument [Line Items]
Aggregate principal amount		$ 400,000,000
2020 Credit Agreement \| Line of Credit \| Revolving credit facility
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity		$ 1,000,000,000

Debt - Interest Rate Swaps (Det

Debt - Interest Rate Swaps (Details) $ in Thousands	3 Months Ended
Debt - Interest Rate Swaps (Details) $ in Thousands	Mar. 31, 2023 USD ($) contract	Dec. 31, 2022 USD ($) contract
Derivative [Line Items]
Number of contracts \| contract	39	139
Interest rate swap contracts total notional value	$ 582,475	$ 1,037,763
Interest rate swaps
Derivative [Line Items]
Term of contract	30 days
Loss on release of interest rate swap recognized in AOCI	$ 47,200
Interest rate swaps \| Minimum
Derivative [Line Items]
Fixed interest rate	3.04%
Interest rate swaps \| Debt Instrument, Redemption, Period One
Derivative [Line Items]
Number of contracts \| contract	1
Interest rate swap contracts total notional value	$ 350,000

Equity - Share Repurchase Progr

Equity - Share Repurchase Program and Share Repurchase Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended
	Apr. 30, 2022	Mar. 31, 2023	Mar. 31, 2022	Feb. 28, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2015
Equity, Class of Treasury Stock [Line Items]
Stock repurchase program, authorized amount							$ 1,200,000
Stock repurchase program, additional authorized amount				$ 400,000	$ 1,000,000	$ 1,600,000
Stock repurchase program, remaining authorized repurchase amount		$ 954,500
Number of shares repurchased (in shares)		327,680	1,627,709
Cash paid for repurchased shares		$ 106,850	$ 451,070
Treasury stock, average price paid per share (in dollars per share)		$ 332.18	$ 284.53
Open Market Purchases
Equity, Class of Treasury Stock [Line Items]
Cash paid for repurchased shares	$ 12,100
Open Market Purchases, Excluded
Equity, Class of Treasury Stock [Line Items]
Cash paid for repurchased shares		$ 2,000

Equity - Changes in AOCI_L by C

Equity - Changes in AOCI/L by Component (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 227,798	$ 371,058
Change in AOCL before reclassifications to income	1,832	(6,798)
Reclassifications from AOCL to income	3,868	5,418
Other comprehensive income (loss), net of tax	5,700	(1,380)
Ending balance	472,858	118,153
Derivative reclassifications	(7,021)	19,734
Interest rate swaps
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Derivative reclassifications	5,100	7,200
Loss to be reclassified within twelve months	19,800
Interest Rate Swaps
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(39,248)	(56,323)
Change in AOCL before reclassifications to income	0	0
Reclassifications from AOCL to income	3,834	5,370
Other comprehensive income (loss), net of tax	3,834	5,370
Ending balance	(35,414)	(50,953)
Defined Benefit Pension Plans
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(4,247)	(6,672)
Change in AOCL before reclassifications to income	0	0
Reclassifications from AOCL to income	34	48
Other comprehensive income (loss), net of tax	34	48
Ending balance	(4,213)	(6,624)
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(58,115)	(18,436)
Change in AOCL before reclassifications to income	1,832	(6,798)
Reclassifications from AOCL to income	0	0
Other comprehensive income (loss), net of tax	1,832	(6,798)
Ending balance	(56,283)	(25,234)
Accumulated Other Comprehensive Loss, Net
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(101,610)	(81,431)
Ending balance	$ (95,910)	$ (82,811)

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 85,494	$ 42,544
Effective income tax rate	22.40%	19.80%
Unrecognized tax benefits	$ 141,000		$ 137,200
Unrecognized tax benefits reductions resulting from anticipated closure of audits and the expiration of certain statutes of limitation	$ 12,300

Derivatives and Hedging - Outst

Derivatives and Hedging - Outstanding Derivatives Contracts (Details) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2023 USD ($) contract	Dec. 31, 2022 USD ($) contract
Derivatives, Fair Value [Line Items]
Number of Contracts \| contract	39	139
Notional Amounts	$ 582,475	$ 1,037,763
Fair Value Asset (Liability), Net	7,107	10,923
Unrealized Loss Recorded in AOCL, net of tax	$ (35,414)	$ (39,248)
Other assets \| Interest rate swaps \| Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Number of Contracts \| contract	1	1
Notional Amounts	$ 350,000	$ 350,000
Fair Value Asset (Liability), Net	1,681	3,952
Unrealized Loss Recorded in AOCL, net of tax	(35,414)	(39,248)
Other current assets \| Interest rate swaps \| Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Fair Value Asset (Liability), Net	$ 5,909	$ 6,346
Other current assets \| Foreign currency forwards \| Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Number of Contracts \| contract		138
Notional Amounts		$ 687,763
Fair Value Asset (Liability), Net		625
Unrealized Loss Recorded in AOCL, net of tax		$ 0
Accrued liabilities \| Foreign currency forwards \| Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Number of Contracts \| contract	38
Notional Amounts	$ 232,475
Fair Value Asset (Liability), Net	(483)
Unrealized Loss Recorded in AOCL, net of tax	$ 0

Derivatives and Hedging - Deriv

Derivatives and Hedging - Derivative Gains And Losses That Have Been Recognized In Condensed Consolidated Statements Of Operations (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Total expense (income), net	$ 7,021	$ (19,734)
Interest expense (income), net
Derivative Instruments, Gain (Loss) [Line Items]
Total expense (income), net	$ 5,117	$ 7,166
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Other (expense) income, net	Other (expense) income, net
Other (income) expense, net
Derivative Instruments, Gain (Loss) [Line Items]
Total expense (income), net	$ 1,904	$ (26,900)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Other (expense) income, net	Other (expense) income, net

Fair Value Disclosures - Assets

Fair Value Disclosures - Assets And Liabilities Measured At Fair Value On Recurring Basis (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Assets:
Total Assets	$ 110,357	$ 103,917
Level 1
Assets:
Total Assets	13,208	6,065
Level 1 \| Deferred compensation plan assets
Assets:
Total Assets	13,208	6,065
Level 2
Assets:
Total Assets	97,149	97,852
Liabilities:
Total Liabilities	108,696	99,252
Level 2 \| Foreign currency forward contracts
Assets:
Total Assets	42	3,236
Liabilities:
Total Liabilities	525	2,611
Level 2 \| Interest rate swap contracts
Assets:
Total Assets	7,590	10,298
Level 2 \| Deferred compensation plan assets
Assets:
Total Assets	89,517	84,318
Level 2 \| Deferred compensation plan liabilities
Liabilities:
Total Liabilities	$ 108,171	$ 96,641

Fair Value Disclosures - Fair V

Fair Value Disclosures - Fair Value of Debt Instruments (Details) - Senior Notes - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Amount	$ 2,179,913	$ 2,179,209
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	2,022,560	1,953,562
2028 Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Amount	793,218	792,934
2028 Notes \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	762,480	740,864
2029 Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Amount	594,158	593,951
2029 Notes \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	539,976	523,842
2030 Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Amount	792,537	792,324
2030 Notes \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	$ 720,104	$ 688,856

Fair Value Disclosures - Narrat

Fair Value Disclosures - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loss on impairment of lease related assets, net	$ 8,720	$ 23,878
Selling, general and administrative
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loss on impairment of lease related assets, net	$ 8,700	$ 23,900

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
Leases - Narrative (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
Lessee, Lease, Description [Line Items]
Renewal term	10 years
Option to terminate, term	1 year
Loss on impairment of lease related assets, net	$ 8,720	$ 23,878
Right-of-use Assets
Lessee, Lease, Description [Line Items]
Loss on impairment of lease related assets, net	6,300	17,700
Leasehold Improvements
Lessee, Lease, Description [Line Items]
Loss on impairment of lease related assets, net	2,400	6,200
Selling, general and administrative
Lessee, Lease, Description [Line Items]
Loss on impairment of lease related assets, net	$ 8,700	$ 23,900

Leases - Net Lease Costs (Detai

Leases - Net Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended
Leases - Net Lease Costs (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
Leases [Abstract]
Operating lease cost	$ 28,799	$ 30,364
Lease cost	4,720	4,268
Sublease income	(12,641)	(10,925)
Total lease cost, net	20,878	23,707
Cash paid for amounts included in the measurement of operating lease liabilities	34,948	34,817
Cash receipts from sublease arrangements	12,439	11,164
Right-of-use assets obtained in exchange for new operating lease liabilities	1,647	6,930
Cost for subleasing activities	10,600	10,500
Loss on impairment of lease related assets, net	$ 8,720	$ 23,878

Leases - Supplemental Balance S

Leases - Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Accounts payable and accrued liabilities	$ 99,674	$ 99,717
Operating lease liabilities	575,963	597,267
Total operating lease liabilities included in the Condensed Consolidated Balance Sheets	$ 675,637	$ 696,984
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Accounts payable and accrued liabilities	Accounts payable and accrued liabilities